10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

___________________________

FORM 10-Q

_________________________

(Mark One)

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the quarterly period ended March 31, 2014

OR

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the transition period from________ to________ .

Commission File Number: 1-644

COLGATE-PALMOLIVE COMPANY

(Exact name of registrant as specified in its charter)

DELAWARE	13-1815595
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

300 Park Avenue, New York, New York	10022
(Address of principal executive offices)	(Zip Code)

(212) 310-2000

(Registrant’s telephone number, including area code)

NO CHANGES

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  x  No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes x  No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check One):

Large accelerated filer x	Accelerated filer ¨
Non-accelerated filer ¨	Smaller reporting company ¨

(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

Class	Shares Outstanding	Date
Common stock, $1.00 par value	915,386,382	March 31, 2014

PART I.FINANCIAL INFORMATION

COLGATE-PALMOLIVE COMPANY

Condensed Consolidated Statements of Income

 (Dollars in Millions Except Per Share Amounts)

(Unaudited)

	Three Months Ended
	March 31,
	2014		2013
Net sales	$	4,325	$	4,315
Cost of sales	1,801		1,800
Gross profit	2,524		2,515
Selling, general and administrative expenses	1,544		1,536
Other (income) expense, net	346		237
Operating profit	634		742
Interest (income) expense, net	7		(3		)
Income before income taxes	627		745
Provision for income taxes	195		239
Net income including noncontrolling interests	432		506
Less: Net income attributable to noncontrolling interests	44		46
Net income attributable to Colgate-Palmolive Company	$	388	$	460
Earnings per common share, basic	$	0.42	$	0.49
Earnings per common share, diluted	$	0.42	$	0.48
Dividends declared per common share *	$	0.70	$	0.65

* Two dividends were declared in each period.

See Notes to Condensed Consolidated Financial Statements.

2

COLGATE-PALMOLIVE COMPANY

Condensed Consolidated Statements of Comprehensive Income

 (Dollars in Millions)

(Unaudited)

	Three Months Ended
	March 31,
	2014			2013
Net income including noncontrolling interests	$	432		$	506
Other comprehensive income (loss), net of tax:
Cumulative translation adjustments	(44		)	(55		)
Retirement plans and other retiree benefit adjustments	13			20
Gains (losses) on available-for-sale securities	(56		)	(4		)
Gains (losses) on cash flow hedges	—			2
Total Other comprehensive income (loss), net of tax	(87		)	(37		)
Total Comprehensive income including noncontrolling interests	345			469
Less: Net income attributable to noncontrolling interests	44			46
Less: Cumulative translation adjustments attributable to noncontrolling interests	(1		)	—
Total Comprehensive income attributable to noncontrolling interests	43			46
Total Comprehensive income attributable to Colgate-Palmolive Company	$	302		$	423

See Notes to Condensed Consolidated Financial Statements.

3

COLGATE-PALMOLIVE COMPANY

Condensed Consolidated Balance Sheets

 (Dollars in Millions)

(Unaudited)

	March 31, 2014			December 31, 2013
Assets
Current Assets
Cash and cash equivalents	$	1,795		$	962
Receivables (net of allowances of $64 and $67, respectively)	1,670			1,636
Inventories	1,478			1,425
Other current assets	734			799
Total current assets	5,677			4,822
Property, plant and equipment:
Cost	8,363			8,330
Less: Accumulated depreciation	(4,326		)	(4,247		)
	4,037			4,083
Goodwill, net	2,485			2,474
Other intangible assets, net	1,500			1,496
Deferred income taxes	75			77
Other assets	658			924
Total assets	$	14,432		$	13,876
Liabilities and Shareholders’ Equity
Current Liabilities
Notes and loans payable	$	24		$	13
Current portion of long-term debt	896			895
Accounts payable	1,264			1,343
Accrued income taxes	253			239
Other accruals	2,265			1,980
Total current liabilities	4,702			4,470
Long-term debt	5,739			4,749
Deferred income taxes	393			444
Other liabilities	1,698			1,677
Total liabilities	12,532			11,340
Shareholders’ Equity
Common stock	1,466			1,466
Additional paid-in capital	1,010			1,004
Retained earnings	17,698			17,952
Accumulated other comprehensive income (loss)	(2,537		)	(2,451		)
Unearned compensation	(26		)	(33		)
Treasury stock, at cost	(15,981		)	(15,633		)
Total Colgate-Palmolive Company shareholders’ equity	1,630			2,305
Noncontrolling interests	270			231
Total shareholders’ equity	1,900			2,536
Total liabilities and shareholders’ equity	$	14,432		$	13,876

See Notes to Condensed Consolidated Financial Statements.

4

COLGATE-PALMOLIVE COMPANY

Condensed Consolidated Statements of Cash Flows

(Dollars in Millions)

(Unaudited)

	Three Months Ended
	March 31,
	2014			2013
Operating Activities
Net income including noncontrolling interests	$	432		$	506
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:
Depreciation and amortization	108			110
Restructuring and termination benefits, net of cash	45			30
Venezuela remeasurement charges	266			172
Stock-based compensation expense	34			32
Deferred income taxes	(21		)	(17		)
Cash effects of changes in:
Receivables	(77		)	(175		)
Inventories	(67		)	(15		)
Accounts payable and other accruals	100			112
Other non-current assets and liabilities	—			22
Net cash provided by operations	820			777
Investing Activities
Capital expenditures	(168		)	(94		)
Purchases of marketable securities and investments	(151		)	(199		)
Proceeds from sale of marketable securities and investments	74			54
Payment for acquisitions, net of cash acquired	(25		)	—
Other	21			7
Net cash used in investing activities	(249		)	(232		)
Financing Activities
Principal payments on debt	(1,938		)	(1,436		)
Proceeds from issuance of debt	2,960			1,553
Dividends paid	(316		)	(290		)
Purchases of treasury shares	(453		)	(385		)
Proceeds from exercise of stock options and excess tax benefits	50			96
Net cash provided by (used in) financing activities	303			(462		)
Effect of exchange rate changes on Cash and cash equivalents	(41		)	(35		)
Net increase (decrease) in Cash and cash equivalents	833			48
Cash and cash equivalents at beginning of the period	962			884
Cash and cash equivalents at end of the period	$	1,795		$	932
Supplemental Cash Flow Information
Income taxes paid	$	171		$	182

See Notes to Condensed Consolidated Financial Statements.

5

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

1. Basis of Presentation

The Condensed Consolidated Financial Statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair statement of the results for interim periods. Results of operations for interim periods may not be representative of results to be expected for a full year. Certain prior year amounts have been reclassified to conform to the current year presentation.

For a complete set of financial statement notes, including the significant accounting policies of Colgate-Palmolive Company (together with its subsidiaries, the “Company” or “Colgate”), refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2013, filed with the Securities and Exchange Commission.

2. Use of Estimates

Provisions for certain expenses, including income taxes, media advertising and consumer promotion, are based on full year assumptions and are included in the accompanying Condensed Consolidated Financial Statements in proportion with estimated annual tax rates, the passage of time or estimated annual sales.

3. Recent Accounting Pronouncements

On April 10, 2014, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2014-08 “Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity.” ASU No. 2014-08 changes the criteria for reporting discontinued operations and modifies related disclosure requirements. The new guidance is effective on a prospective basis for fiscal years beginning after December 15, 2014, and interim periods within annual periods beginning on or after December 15, 2015. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.

4. Acquisitions and Divestitures

Sale of Land in Mexico

On September 13, 2011, the Company’s Mexican subsidiary entered into an agreement to sell to the United States of America the Mexico City site on which its commercial operations, technology center and soap production facility are located. The sale price is payable in three installments, with the final installment due upon the transfer of the property, which is expected to occur in 2014. During the third quarter of 2011, the Company received the first installment of $24 upon signing the agreement. During the third quarter of 2012, the Company received the second installment of $36. The Company is reinvesting these payments to relocate its soap production to a new state-of-the-art facility at its Mission Hills, Mexico site, to relocate its commercial and technology operations within Mexico City and to prepare the existing site for transfer. Exit costs incurred during the project primarily relate to staff leaving indemnities, accelerated depreciation and demolition to make the site building-ready. During the three months endedMarch 31, 2014 and 2013, the Company recorded $1 and $5 of pretax costs ($1 and $3 of aftertax costs), respectively, related to the sale.

5. Restructuring and Related Implementation Charges

In the fourth quarter of 2012, the Company commenced a four-year Global Growth and Efficiency Program (the “2012 Restructuring Program”) for sustained growth. The program’s initiatives are expected to help Colgate ensure continued solid worldwide growth in unit volume, organic sales and earnings per share and enhance its global leadership positions in its core businesses.

Implementation of the 2012 Restructuring Program is projected to result in cumulative pretax charges, once all phases are approved and implemented, totaling between $1,100 and $1,250 ($775 and $875 aftertax), which are currently estimated to be comprised of the following categories: Employee-Related Costs, including severance, pension and other termination benefits (50%); asset-related costs, primarily Incremental Depreciation and Asset Impairments (15%); and Other charges, which include contract termination costs, consisting primarily of implementation-related charges resulting directly from exit activities (20%) and the implementation of new strategies (15%). Anticipated pretax charges for 2014 are expected to

6

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

amount to approximately $275 to $325 ($200 to $230 aftertax). Over the course of the 2012 Restructuring Program, it is estimated that approximately 75% of the charges will result in cash expenditures.

It is expected that the cumulative pretax charges, once all projects are approved and implemented, will relate to initiatives undertaken in North America (15%), Europe/South Pacific (20%), Latin America (5%), Asia (5%), Africa/Eurasia (5%), Hill’s Pet Nutrition (10%) and Corporate (40%), which includes substantially all of the costs related to the implementation of new strategies, noted above, on a global basis. It is expected that by the end of 2016, the 2012 Restructuring Program will reduce the Company’s global employee workforce by approximately 6% from the 2012 level of approximately 38,000.

For the three months ended March 31, 2014 and 2013, restructuring and implementation-related charges are reflected in the income statement as follows:

	Three Months Ended March 31,
	2014		2013
Cost of sales	$	10	$	8
Selling, general and administrative expenses	17		8
Other (income) expense, net	75		50
Total 2012 Restructuring Program charges, pretax	$	102	$	66
Total 2012 Restructuring Program charges, aftertax	$	73	$	52

Restructuring and related implementation charges in the preceding table are recorded in the Corporate segment as these initiatives are predominantly centrally directed and controlled and are not included in internal measures of segment operating performance. Total charges for the 2012 Restructuring Program for the three months endedMarch 31, 2014 relate to initiatives undertaken in North America (9%), Europe/South Pacific (21%), Latin America (4%), Africa/Eurasia (2%), Hill’s Pet Nutrition (8%) and Corporate (56%). Total charges for the 2012 Restructuring Program for the three months endedMarch 31, 2013 relate to initiatives undertaken in Europe/South Pacific (31%), Latin America (15%), Africa/Eurasia (6%), Hill’s Pet Nutrition (3%) and Corporate (45%). Total program-to-date accumulated charges for the 2012 Restructuring Program relate to initiatives undertaken in North America (10%), Europe/South Pacific (31%), Latin America (3%), Africa/Eurasia (5%), Hill’s Pet Nutrition (7%) and Corporate (44%).

Since the inception of the 2012 Restructuring Program in the fourth quarter of 2012, the Company has incurred pretax cumulative charges of $562 ($421 aftertax) in connection with the implementation of various projects as follows:

	Cumulative Charges
	as of March 31, 2014
Employee-Related Costs	$	242
Incremental Depreciation	32
Asset Impairments	1
Other	287
Total	$	562

The majority of costs incurred since inception relate to the following projects: restructuring how the Company provides retirement benefits to its U.S.-based employees by shifting them from the Company’s defined benefit retirement plan to the Company’s defined contribution plan; the closing of the Morristown, New Jersey personal care facility; the simplification and streamlining of the Company’s research and development capabilities and oral care supply chain, both in Europe; the consolidation of facilities; the implementation of the Company’s hubbing strategy in Europe; and the extension of shared business services and streamlining global functions.

7

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

The following table summarizes the activity for the restructuring and implementation-related charges discussed above and the related accruals:

	Three Months Ended March 31, 2014
	Employee-Related Costs			Incremental Depreciation			Asset Impairments		Other			Total
Balance at December 31, 2013	$	116		$	—		$	—	$	42		$	158
Charges	20			6			—		76			102
Cash payments	(31		)	—			—		(23		)	(54		)
Charges against assets	(1		)	(6		)	—		—			(7		)
Foreign exchange	(1		)	—			—		(1		)	(2		)
Balance at March 31, 2014	$	103		$	—		$	—	$	94		$	197

Employee-Related Costs primarily include severance and other termination benefits and are calculated based on long-standing benefit practices, local statutory requirements and, in certain cases, voluntary termination arrangements. Employee-Related Costs also include pension enhancements amounting to $1 for the three months ended March 31, 2014, which are reflected as Charges against assets within Employee-Related Costs in the preceding tables as the corresponding balance sheet amounts are reflected as a reduction of pension assets or an increase in pension liabilities.

Incremental Depreciation is recorded to reflect changes in useful lives and estimated residual values for long-lived assets that will be taken out of service prior to the end of their normal service period. Asset Impairments are recorded to write down assets held for sale or disposal to their fair value based on amounts expected to be realized. Charges against assets within Asset Impairments are net of cash proceeds pertaining to the sale of certain assets.

Other charges consist primarily of charges resulting directly from exit activities and the implementation of new strategies as a result of the 2012 Restructuring Program. These charges for the three months ended March 31, 2014 included third-party incremental costs related to the development and implementation of new business and strategic initiatives of $16 and contract termination costs and charges resulting directly from exit activities of $21 directly related to the 2012 Restructuring Program. These charges were expensed as incurred. Also included in Other charges for the three months ended March 31, 2014 are other exit costs related to the consolidation of facilities of $39.

6. Inventories

Inventories by major class are as follows:

	March 31, 2014		December 31, 2013
Raw materials and supplies	$	338	$	340
Work-in-process	63		60
Finished goods	1,077		1,025
Total Inventories	$	1,478	$	1,425

8

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

7. Shareholders’ Equity

Changes in the components of Shareholders’ Equity for the three months endedMarch 31, 2014 are as follows:

	Colgate-Palmolive Company Shareholders’ Equity																	Noncontrolling Interests
	Common Stock		Additional Paid-in Capital			Unearned Compensation			Treasury Stock			Retained Earnings			Accumulated Other Comprehensive Income (Loss)
Balance, December 31, 2013	$	1,466	$	1,004		$	(33	)	$	(15,633	)	$	17,952		$	(2,451	)	$	231
Net income												388						44
Other comprehensive income (loss), net of tax															(86		)	(1		)
Dividends												(642		)				(4		)
Stock-based compensation expense			34
Shares issued for stock options			9						65
Shares issued for restricted stock awards			(40		)				40
Treasury stock acquired									(453		)
Other			3			7
Balance, March 31, 2014	$	1,466	$	1,010		$	(26	)	$	(15,981	)	$	17,698		$	(2,537	)	$	270

Accumulated other comprehensive income (loss) includes cumulative translation losses of $1,815 and $1,772 at March 31, 2014 and December 31, 2013, respectively, and unrecognized retirement plan and other retiree benefits costs of $722 and $735 at March 31, 2014 and December 31, 2013, respectively.

8. Earnings Per Share

	Three Months Ended
	March 31, 2014					March 31, 2013
	Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share
Basic EPS	$	388	919.5	$	0.42	$	460	936.6	$	0.49
Stock options and restricted stock			9.1					8.4
Diluted EPS	$	388	928.6	$	0.42	$	460	945.0	$	0.48

For the three months endedMarch 31, 2014 and 2013, the average number of stock options and restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 3,374,995 and 3,750,570, respectively.

Basic and diluted earnings per share are computed independently for each quarter and any year-to-date period presented. As a result of changes in shares outstanding during the year and rounding, the sum of the quarters’ earnings per share may not necessarily equal the earnings per share for any year-to-date period.

9

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

9. Other Comprehensive Income (Loss)

Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the three months endedMarch 31, 2014 and 2013 were as follows:

	2014						2013
	Pretax			Net of Tax			Pretax			Net of Tax
Cumulative translation adjustments	$	(39	)	$	(43	)	$	(45	)	$	(55	)
Retirement plans and other retiree benefits:
Net actuarial gain (loss) and prior service costs arising during the period	3			2			3			2
Amortization of net actuarial loss, transition and prior service costs (1)	14			11			26			18
Retirement plans and other retiree benefits adjustments	17			13			29			20
Available-for-sale securities:
Unrealized gains (losses) on available-for-sale securities (2)	(298		)	(194		)	(141		)	(90		)
Reclassification of (gains) losses into net earnings on available-for-sale securities (3)	211			138			133			86
Gains (losses) on available-for-sale securities	(87		)	(56		)	(8		)	(4		)
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges	2			1			7			5
Reclassification of (gains) losses into net earnings on cash flow hedges (4)	(3		)	(1		)	(4		)	(3		)
Gains (losses) on cash flow hedges	(1		)	—			3			2
Total Other comprehensive income (loss)	$	(110	)	$	(86	)	$	(21	)	$	(37	)

⁽¹⁾These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 10, Retirement Plans and Other Retiree Benefits for additional details.

⁽²⁾For the three months ended March 31, 2014, these amounts included pretax losses of $276 related to the remeasurement of the bolivar denominated fixed interest rate bonds and the devaluation-protected bonds in Venezuela as a result of the effective devaluation in the first quarter of 2014.

For the three months ended March 31, 2013, these amounts included pretax losses of $133 only related to the remeasurement of the bolivar denominated fixed interest rate bonds in Venezuela as a result of the devaluation in the first quarter of 2013. No remeasurement charge was required on the devaluation-protected bonds in the first quarter of 2013 since the official exchange rate changed from 4.30 to 6.30 bolivares per dollar and the devaluation-protected bonds revalued to the official exchange rate. See Note 13, Fair Value Measurements and Financial Instruments for additional details.

⁽³⁾Represents reclassification of (gains) losses on the Venezuela bonds into Other (income) expense, net due to an impairment in the fair value of the bonds as a result of the effective devaluation in the first quarter of 2014 and the devaluation in the first quarter of 2013. See Note 13, Fair Value Measurements and Financial Instruments for additional details.

⁽⁴⁾These (gains) losses are reclassified into Cost of sales. See Note 13, Fair Value Measurements and Financial Instruments for additional details.

There were no tax impacts on Other comprehensive income (loss) attributable to Noncontrolling interests.

10

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

10. Retirement Plans and Other Retiree Benefits

Components of Net periodic benefit cost for the three-month periods ended March 31, 2014 and 2013 were as follows:

	Pension Benefits												Other Retiree Benefits
	United States						International
	Three Months Ended March 31,
	2014			2013			2014			2013			2014		2013
Service cost	$	—		$	7		$	5		$	6		$	3	$	4
Interest cost	25			23			9			7			10		10
Expected return on plan assets	(27		)	(29		)	(7		)	(6		)	—		(1		)
Amortization of transition and prior service costs (credits)	—			2			1			—			—		—
Amortization of actuarial loss (gain)	8			16			1			3			4		5
Net periodic benefit cost	$	6		$	19		$	9		$	10		$	17	$	18

For each of the three months endedMarch 31, 2014 and 2013, the Company did not make any voluntary contributions to its U.S. postretirement plans.

11. Contingencies

As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, environmental and tax matters and consumer class actions. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites.

As a matter of course, the Company is regularly audited by the IRS and other tax authorities around the world in countries where it conducts business. In this regard, all U.S. federal income tax returns through December 31, 2009 have been audited by, and settled with, the IRS. With a few exceptions, the Company is no longer subject to U.S., state and local income tax examinations for the years prior to 2009. In addition, the Company has subsidiaries in various foreign jurisdictions that have statutes of limitations for tax audits generally ranging from three to six years.

The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances.

11

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $250 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company from the matters in question. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above.

Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more of these matters could be material to the Company’s results of operations or cash flows for any particular quarter or year.

Brazilian Matters

There are certain tax and civil proceedings outstanding, as described below, related to the Company’s 1995 acquisition of the Kolynos oral care business from Wyeth (the “Seller”).

The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, at the current exchange rate, are approximately $120. The Company has been disputing the disallowances by appealing the assessments within the internal revenue authority’s appellate process with the following results to date:

▪ In June 2005, the First Board of Taxpayers ruled in the Company’s favor and allowed all of the previously claimed deductions for 1996 through 1998. In March 2007, the First Board of Taxpayers ruled in the Company’s favor and allowed all of the previously claimed deductions for 1999 through 2001. The tax authorities appealed these decisions to the next administrative level.

▪ In August 2009, the First Taxpayers’ Council (the next and final administrative level of appeal) overruled the decisions of the First Board of Taxpayers, upholding the majority of the assessments, disallowing a portion of the assessments and remanding a portion of the assessments for further consideration by the First Board of Taxpayers.

The Company has filed a motion for clarification with a special appeals chamber of the Taxpayers’ Council, and further appeals are available within the Brazilian federal courts. The Company intends to challenge these assessments vigorously. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel and other advisors, that the disallowances are without merit and that the Company should ultimately prevail on appeal, if necessary, in the Brazilian federal courts.

In 2002, the Brazilian Federal Public Attorney filed a civil action against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company, as represented by its Brazilian subsidiary, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The action seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the Company should ultimately prevail in this action. The Company intends to challenge this action vigorously.

12

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest and penalties of approximately $75, at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. The Company is disputing the assessment within the internal revenue authority’s administrative appeals process. In October 2007, the Second Board of Taxpayers, which has jurisdiction over these matters, ruled in favor of the internal revenue authority. In January 2008, the Company appealed this decision, and in January 2012, a special appeals chamber of the Taxpayers’ Council denied the Company’s appeal. The Company has filed a motion for clarification with a special appeals chamber of the Taxpayers’ Council and further appeals are available within the Brazilian federal courts. Although there can be no assurances, management believes, based on the advice of its Brazilian legal counsel, that the tax assessment is without merit and that the Company should prevail on appeal, if not at the administrative level, in the Brazilian federal courts. The Company intends to challenge this assessment vigorously.

Competition Matters

European Competition Matters

Certain of the Company’s subsidiaries in Europe are subject to investigations, and in some cases, fines by governmental authorities in a number of European countries related to potential competition law violations. The Company understands that substantially all of these matters also involve other consumer goods companies and/or retail customers. The status of the various pending matters is discussed below.

Fines have been imposed on the Company in the following matters, although, as noted below, the Company has appealed each of these fines:

▪ In December 2009, the Swiss competition law authority imposed a fine of $6 on the Company’s GABA subsidiary for alleged violations of restrictions on parallel imports into Switzerland, which the Company appealed. In January 2014, this appeal was denied. The Company is appealing before the Swiss Supreme Court.

▪ In January 2010, the Company’s Spanish subsidiary was fined $3 by the Spanish competition law authority on the basis that it had entered an agreement with other shower gel manufacturers regarding product downsizing, which the Company contested. The fine was annulled by the Court of Appeal in July 2013. The Spanish competition law authority is appealing this judgment before the Spanish Supreme Court.

▪ In December 2010, the Italian competition law authority found that 16 consumer goods companies, including the Company’s Italian subsidiary, exchanged competitively sensitive information in the cosmetics sector, for which the Company’s Italian subsidiary was fined $3. The Company is appealing the fine in the Italian courts.

▪ In March 2012, the French competition law authority found that three pet food producers, including the Company’s Hill’s French subsidiary, had violated the competition law, for which it imposed a fine of $7 on the Company’s Hill’s French subsidiary for alleged restrictions on exports from France, which the Company contested. In October 2013, the Company’s appeal was denied. The Company is appealing before the French Supreme Court.

Currently, formal claims of violations, or statements of objections, are pending against the Company as follows:

▪ In October 2012, the Belgian competition law authority alleged that 11 branded goods companies, including the Company’s Belgian subsidiary, assisted retailers to coordinate their retail prices on the Belgian market. The Company is in the process of responding to this statement of objections.

▪ In June 2013, the French competition law authority issued a statement of objections alleging that the Company’s French subsidiary and a number of its competitors exchanged sensitive information related to the French home care and personal care sectors. The Company has responded to this statement of objections.

An investigation is ongoing in Greece, but no formal claim of violations has been filed.

13

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Since December 31, 2013, the following matter has been resolved:

▪ In January 2014, the French Court of Appeal confirmed the French competition law authority’s December 2011 fine of the Company’s French subsidiary, in the amount of $46, in connection with a divested heavy duty detergent business.

Australian Competition Matter

In December 2013, the Australian competition law authority instituted civil proceedings in the Sydney registry of the Federal Court of Australia alleging that three consumer goods companies, including the Company’s Australian subsidiary, a retailer and a former employee of the Company’s Australian subsidiary violated the Australian competition law by coordinating the launching and pricing of ultra concentrated laundry detergents. The Company intends to challenge these proceedings vigorously. Since the amount of any potential losses from these proceedings currently cannot be estimated, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to these proceedings.

The Company’s policy is to comply with antitrust and competition laws and, if a violation of any such laws is found, to take appropriate remedial action and to cooperate fully with any related governmental inquiry. Competition and antitrust law investigations often continue for several years and can result in substantial fines for violations that are found. While the Company cannot predict the final financial impact of these competition law issues as these matters may change, the Company evaluates developments in these matters quarterly and accrues liabilities as and when appropriate.

Talcum Powder Matters

The Company is a defendant in a number of civil actions alleging that certain talc products it sold prior to 1996 were contaminated with asbestos. Since 2008, the Company has and will continue to challenge these cases vigorously, and although there can be no assurances, it believes, based on the advice of its legal counsel, that they are without merit and the Company should ultimately prevail. Currently, there are 12 single plaintiff cases pending against the Company in state courts in Delaware, Maryland, New Jersey and New York and one case pending in federal court in North Carolina. Fourteen similar cases previously filed against the Company have been dismissed and final judgment entered in favor of the Company. To date, there have been no findings of liability against the Company in any of these cases. Since the amount of any potential losses from these cases at trial currently cannot be estimated, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to these cases.

In 2014, two of these cases are tentatively scheduled to go to trial, although the Company may succeed in dismissing some or all of them prior to trial. As stated above, the Company believes that it will ultimately prevail as it has in all similar cases.

14

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

ERISA Matters

In October 2007, a putative class action claiming that certain aspects of the cash balance portion of the Colgate-Palmolive Company Employees’ Retirement Income Plan (the “Plan”) do not comply with the Employee Retirement Income Security Act was filed against the Plan and the Company in the United States District Court for the Southern District of New York. Specifically, Proesel, et al. v. Colgate-Palmolive Company Employees’ Retirement Income Plan, et al. alleges improper calculation of lump sum distributions, age discrimination and failure to satisfy minimum accrual requirements, thereby resulting in the underpayment of benefits to Plan participants.

Two other putative class actions filed earlier in 2007, Abelman, et al. v. Colgate-Palmolive Company Employees’ Retirement Income Plan, et al., in the United States District Court for the Southern District of Ohio, and Caufield v. Colgate-Palmolive Company Employees’ Retirement Income Plan, in the United States District Court for the Southern District of Indiana, both alleging improper calculation of lump sum distributions and, in the case of Abelman, claims for failure to satisfy minimum accrual requirements, were transferred to the Southern District of New York and consolidated with Proesel into one action, In re Colgate-Palmolive ERISA Litigation. The complaint in the consolidated action alleges improper calculation of lump sum distributions and failure to satisfy minimum accrual requirements, but does not include a claim for age discrimination. The relief sought includes recalculation of benefits in unspecified amounts, pre- and post-judgment interest, injunctive relief and attorneys’ fees. In October 2013, the parties executed a settlement agreement under which the Plan would pay approximately $40 after application of certain offsets to resolve the litigation. The settlement agreement is subject to court approval. On December 16, 2013, a motion for preliminary approval of a class action settlement, class certification and appointment of class counsel was approved. A final approval hearing was held on April 4, 2014 and the court is considering final approval. The Company and the Plan intend to contest this action vigorously should the settlement not be approved and finalized.

15

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

12. Segment Information

The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition.  The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.

The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of corporate-driven decisions related to interest expense and income taxes. Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation costs and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of operating segment performance used by the Company to measure the underlying performance of the operating segments.

Net sales and Operating profit by segment were as follows:

	Three Months Ended
	March 31,
	2014			2013
Net sales
Oral, Personal and Home Care
North America	$	785		$	764
Latin America	1,152			1,214
Europe/South Pacific	865			848
Asia	672			655
Africa/Eurasia	298			300
Total Oral, Personal and Home Care	3,772			3,781
Pet Nutrition	553			534
Total Net sales	$	4,325		$	4,315
Operating profit
Oral, Personal and Home Care
North America	$	216		$	215
Latin America	290			312
Europe/South Pacific	217			200
Asia	193			186
Africa/Eurasia	59			62
Total Oral, Personal and Home Care	975			975
Pet Nutrition	144			136
Corporate	(485		)	(369		)
Total Operating profit	$	634		$	742

16

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Approximately 80% of the Company’s Net sales are generated from markets outside the U.S., with over 50% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe).

For the three months ended March 31, 2014, Corporate Operating profit (loss) includes charges of $102 associated with the 2012 Restructuring Program, a charge of $266 related to the Venezuela remeasurement and costs of $1 related to the sale of land in Mexico. For the three months ended March 31, 2013, Corporate Operating profit (loss) included charges of $66 associated with the 2012 Restructuring Program, a charge of $172 related to the Venezuela remeasurement and costs of $5 related to the sale of land in Mexico. For further information regarding the 2012 Restructuring Program, refer to Note 5, Restructuring and Related Implementation Charges. For further information regarding Venezuela, refer to Note 14, Venezuela. For further information regarding the sale of land in Mexico, refer to Note 4, Acquisitions and Divestitures.

13. Fair Value Measurements and Financial Instruments

The Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material, as it is the Company’s policy to contract only with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations.

The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, sourcing strategies, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose. It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged. Hedge ineffectiveness, if any, is not material for any period presented.  

The Company’s derivative instruments include interest rate swap contracts, foreign currency contracts and commodity contracts. The Company utilizes interest rate swap contracts to manage its targeted mix of fixed and floating rate debt, and these swaps are valued using observable benchmark rates (Level 2 valuation). The Company utilizes foreign currency contracts, including forward, option and swap contracts, local currency deposits and local currency borrowings to hedge portions of its foreign currency purchases, assets and liabilities arising in the normal course of business and the net investment in certain foreign subsidiaries. These contracts are valued using observable market rates (Level 2 valuation). Commodity futures contracts are utilized to hedge the purchases of raw materials used in production. These contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of foreign currency and commodity contracts generally does not exceed 12 months.

17

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

The following summarizes the fair value of the Company’s derivative instruments and other financial instruments at March 31, 2014 and December 31, 2013:

	Assets					Liabilities
	Account	Fair Value				Account	Fair Value
Designated derivative instruments		3/31/14		12/31/13			3/31/14		12/31/13
Interest rate swap contracts	Other current assets	$	—	$	1	Other accruals	$	—	$	—
Interest rate swap contracts	Other assets	17		20		Other liabilities	7		1
Foreign currency contracts	Other current assets	7		14		Other accruals	7		8
Foreign currency contracts	Other assets	—		—		Other liabilities	7		10
Commodity contracts	Other current assets	1		—		Other accruals	—		—
Total designated		$	25	$	35		$	21	$	19
Derivatives not designated
Foreign currency contracts	Other current assets	$	—	$	—	Other accruals	$	4	$	3
Total not designated		$	—	$	—		$	4	$	3
Total derivative instruments		$	25	$	35		$	25	$	22
Other financial instruments
Marketable securities	Other current assets	$	243	$	173
Available-for-sale securities	Other assets	393		685
Total other financial instruments		$	636	$	858

The carrying amount of cash, cash equivalents, accounts receivable and short-term debt approximated fair value as of March 31, 2014 and December 31, 2013. The estimated fair value of the Company’s long-term debt, including the current portion, as of March 31, 2014 and December 31, 2013, was $6,733 and $5,690, respectively, and the related carrying value was $6,635 and $5,644, respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation).

18

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Fair value hedges

The Company has designated all interest rate swap contracts and certain foreign currency forward and option contracts as fair value hedges, for which the gain or loss on the derivative and the offsetting loss or gain on the hedged item are recognized in current earnings. The impact of foreign currency contracts is primarily recognized in Selling, general and administrative expenses and the impact of interest rate swap contracts is recognized in Interest (income) expense, net.

Activity related to fair value hedges recorded during the three-month periods ended March 31, 2014 and 2013 was as follows:

	2014									2013
	Foreign Currency Contracts			Interest Rate Swaps			Total			Foreign Currency Contracts			Interest Rate Swaps			Total
Notional Value at March 31,	$	681		$	1,688		$	2,369		$	1,085		$	1,338		$	2,423
Three months ended March 31:
Gain (loss) on derivative	2			(10		)	(8		)	12			(7		)	5
Gain (loss) on hedged items	(2		)	10			8			(12		)	7			(5		)

Cash flow hedges

All of the Company’s commodity contracts and certain foreign currency forward contracts have been designated as cash flow hedges, for which the effective portion of the gain or loss is reported as a component of Other comprehensive income (“OCI”) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings.

Activity related to cash flow hedges recorded during the three-month periods ended March 31, 2014 and 2013 was as follows:

	2014						2013
	Foreign Currency Contracts		Commodity Contracts		Total		Foreign Currency Contracts		Commodity Contracts			Total
Notional Value at March 31,	$	401	$	15	$	416	$	446	$	52		$	498
Three months ended March 31:
Gain (loss) recognized in OCI	—		2		2		8		(1		)	7
Gain (loss) reclassified into Cost of sales	2		1		3		3		1			4

The net gain (loss) recognized in OCI for both foreign currency contracts and commodity contracts is expected to be recognized in Cost of sales within the next twelve months.

19

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Net investment hedges

The Company has designated certain foreign currency forward and option contracts and certain foreign currency-denominated debt as net investment hedges, for which the gain or loss on the instrument is reported as a component of Currency translation adjustments within OCI, along with the offsetting gain or loss on the hedged items.

Activity related to net investment hedges recorded during the three-month periods ended March 31, 2014 and 2013 was as follows:

	2014							2013
	Foreign Currency Contracts		Foreign Currency Debt			Total		Foreign Currency Contracts			Foreign Currency Debt			Total
Notional Value at March 31,	$	680	$	256		$	936	$	536		$	375		$	911
Three months ended March 31:
Gain (loss) on instruments	—		1			1		14			13			27
Gain (loss) on hedged items	1		(1		)	—		(13		)	(13		)	(26		)

Derivatives Not Designated as Hedging Instruments

Derivatives not designated as hedging instruments for each period consist of a cross-currency swap that serves as an economic hedge of a foreign currency deposit, for which the gain or loss on the instrument and the offsetting gain or loss on the hedged item are recognized in Other (income) expense, net for each period. 

Activity related to these contracts during the three-month periods ended March 31, 2014 and 2013 was as follows:

	2014			2013
	Cross-currency Swap			Cross-currency Swap
Notional Value at March 31,	$	96		$	96
Three months ended March 31:
Gain (loss) on instrument	(1		)	6
Gain (loss) on hedged item	1			(6		)

20

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

Other Financial Instruments

Other financial instruments are classified as Other current assets or Other assets.

Other financial instruments classified as Other current assets include marketable securities, which consist of bank deposits of $195 with original maturities greater than 90 days (Level 1 valuation) and the current portion of bonds issued by the Venezuelan government (Level 2 valuation) in the amount of $48. The long-term portion of these bonds in the amount of $393 is included in Other assets.

Through its subsidiary in Venezuela, the Company is invested in U.S. dollar-linked, devaluation-protected bonds and bolivar denominated fixed interest rate bonds, both of which are issued by the Venezuelan government. These bonds are actively traded and, therefore, are considered Level 2 investments as their values are determined based upon observable market-based inputs or unobservable inputs that are corroborated by market data. As of March 31, 2014, the fair market value of U.S. dollar-linked devaluation-protected bonds and bolivar denominated fixed interest rate bonds was $137 and $304, respectively. These bonds are considered available-for-sale securities and, as noted above, the long-term portion in the amount of $393 is included in Other assets.

The following table presents a reconciliation of the Venezuelan bonds at fair value for the three months endedMarch 31, 2014 and 2013:

	2014			2013
Beginning balance as of January 1,	$	685		$	642
Unrealized gain (loss) on investment	(298		)	(141		)
Purchases and sales during the period	54			97
Ending balance as of March 31,	$	441		$	598

Unrealized loss on investment for the three months ended March 31, 2014 consisted primarily of a charge in the amount of $276 related to the remeasurement of the bolivar denominated fixed interest rate bonds and the devaluation-protected bonds in Venezuela as a result of the effective devaluation in the first quarter of 2014.

Unrealized loss on investment for the three months ended March 31, 2013 consisted primarily of a charge in the amount of $133 only related to the remeasurement of the bolivar denominated fixed interest rate bonds in Venezuela as a result of the devaluation in the first quarter of 2013. No remeasurement charge was required on the devaluation-protected bonds in the first quarter of 2013 since the official exchange rate changed from 4.30 to 6.30 bolivares per dollar and the devaluation-protected bonds revalued to the official exchange rate.

For further information regarding Venezuela, refer to Note 14, Venezuela.

21

COLGATE-PALMOLIVE COMPANY

Notes to Condensed Consolidated Financial Statements (continued)

(Dollars in Millions Except Share and Per Share Amounts)

(Unaudited)

14.    Venezuela

Venezuela has been designated hyper-inflationary and, therefore, the functional currency for the Company’s Venezuelan subsidiary (“CP Venezuela”) is the U.S. dollar and Venezuelan currency fluctuations are reported in income.

During the first quarter of 2014, the Venezuelan government enacted several changes to Venezuela’s foreign exchange regime, introducing a multi-tier foreign exchange system whereby there are now three exchange rate mechanisms available to convert Venezuelan bolivares to U.S. dollars. The Venezuelan government replaced CADIVI with a new foreign currency administration, the National Center for Foreign Commerce (“CENCOEX”). Although the official exchange rate remains at 6.30 bolivares per dollar, the exchange rate for foreign investments moved to the rate available on the SICAD I (Supplementary System for the Administration of Foreign Currency) currency market which, in the last auction during the first quarter of 2014, was 10.70 bolivares per dollar. As part of the changes in Venezuela’s foreign exchange system enacted in the first quarter of 2014, the Venezuelan government also introduced an alternative currency market known as SICAD II.

The Company remeasures the financial statements of CP Venezuela at the end of each month at the rate at which it expects to remit future dividends which, based on the advice of legal counsel, is the SICAD I rate. Effective with the quarter ended March 31, 2014, the Company remeasured the majority of CP Venezuela’s local currency-denominated net monetary assets at the quarter-end SICAD I rate and incurred a pretax loss of $266 ($174 aftertax loss or $0.19 per diluted common share). Included in the loss is a charge related to the devaluation-protected bonds issued by the Venezuelan government and held by CP Venezuela. Because the official exchange rate remains at 6.30 bolivares per dollar, the devaluation-protected bonds did not revalue at the rate available on the SICAD I currency market but remained at the official exchange rate. CP Venezuela continues to be able to settle certain of its U.S. dollar obligations for imported materials at the official rate of 6.30 bolivares per dollar and records the gains related to such transactions when the funds are authorized by CENCOEX and the liabilities are paid.

In the first quarter of 2013, the Company incurred a pretax loss of $172 ($111 aftertax loss) related to the remeasurement of the net monetary assets in the local balance sheet at the date of the devaluation that changed the official exchange rate from 4.30 to 6.30 bolivares per dollar.

For the three months endedMarch 31, 2014, CP Venezuela represented approximately 3% of the Company’s consolidated Net sales. CP Venezuela incurred a small operating loss for the quarter ended March 31, 2014, which was insignificant in relation to the Company’s consolidated Operating profit. At March 31, 2014, CP Venezuela’s local currency-denominated net monetary asset position, which would be subject to remeasurement in the event of further changes in the SICAD I rate, was approximately $489. This amount includes the devaluation-protected bonds issued by the Venezuelan government. CP Venezuela’s local currency-denominated non-monetary assets were approximately $337 at March 31, 2014 and included approximately $226 of fixed assets that could be subject to impairment if CP Venezuela continues to be unable to implement price increases to offset the impacts of continued high inflation or further devaluations, or if it does not have sufficient access to U.S. dollars to fund imports.

22

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

Executive Overview and Outlook

Colgate-Palmolive Company seeks to deliver strong, consistent business results and superior shareholder returns by providing consumers globally with products that make their lives healthier and more enjoyable.

To this end, the Company is tightly focused on two product segments: Oral, Personal and Home Care; and Pet Nutrition. Within these segments, the Company follows a closely defined business strategy to develop and increase market leadership positions in key product categories. These product categories are prioritized based on their capacity to maximize the use of the organization’s core competencies and strong global equities and to deliver sustainable long-term growth.

Operationally, the Company is organized along geographic lines with management teams having responsibility for the business and financial results in each region. The Company competes in more than 200 countries and territories worldwide with established businesses in all regions contributing to the Company’s sales and profitability. Approximately 80% of the Company’s Net sales are generated from markets outside the U.S., with over 50% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). This geographic diversity and balance help to reduce the Company’s exposure to business and other risks in any one country or part of the world.

The Oral, Personal and Home Care segment is operated through five reportable operating segments: North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia, all of which sell to a variety of retail and wholesale customers and distributors. The Company, through Hill’s Pet Nutrition, also competes on a worldwide basis in the pet nutrition market, selling its products principally through authorized pet supply retailers and veterinarians.

On an ongoing basis, management focuses on a variety of key indicators to monitor business health and performance. These indicators include market share, net sales (including volume, pricing and foreign exchange components), organic sales growth (net sales growth excluding the impact of foreign exchange, acquisitions and divestments), gross profit margin, operating profit, net income and earnings per share, as well as measures used to optimize the management of working capital, capital expenditures, cash flow and return on capital. The monitoring of these indicators and the Company’s Code of Conduct and corporate governance practices help to maintain business health and strong internal controls.

To achieve its business and financial objectives, the Company focuses the organization on initiatives to drive and fund growth. The Company seeks to capture significant opportunities for growth by identifying and meeting consumer needs within its core categories, through its focus on innovation and the deployment of valuable consumer and shopper insights in the development of successful new products regionally, which are then rolled out on a global basis. To enhance these efforts, the Company has developed key initiatives to build strong relationships with consumers, dental and veterinary professionals and retail customers. Growth opportunities are greater in those areas of the world in which economic development and rising consumer incomes expand the size and number of markets for the Company’s products.

The investments needed to support growth are developed through continuous, Company-wide initiatives to lower costs and increase effective asset utilization. Through these initiatives, which are referred to as the Company’s funding-the-growth initiatives, the Company seeks to become even more effective and efficient throughout its businesses. These initiatives are designed to reduce costs associated with direct materials, indirect expenses and distribution and logistics and encompass a wide range of projects, examples of which include raw material substitution, reduction of packaging materials, consolidating suppliers to leverage volumes and increasing manufacturing efficiency through SKU reductions and formulation simplification. The Company also continues to prioritize its investments toward its higher margin businesses, specifically Oral Care, Personal Care and Pet Nutrition.

23

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

With approximately 80% of its Net sales generated outside the United States, the Company is exposed to changes in economic conditions and foreign currency exchange rates, as well as political uncertainty in some countries, all of which could impact future operating results. For example, as discussed in detail below, the operating environment in Venezuela is challenging, with economic uncertainty fueled by currency devaluations and high inflation and governmental restrictions in the form of import authorization controls, currency exchange and payment controls, price and profit controls and the possibility of expropriation of property or other resources. Price controls, which became effective on April 1, 2012, affect most products in the portfolio of the Company’s Venezuelan subsidiary (“CP Venezuela”) and thereby further restrict the Company’s ability to implement price increases, which had been one of the key mechanisms to offset the effects of continuing high inflation and the impact of currency devaluations. In particular, the Company has been and will continue to be impacted as a result of the significant devaluations of the Venezuelan bolivar that occurred in 2010 and in February 2013, and the effective devaluation in 2014 as a result of the introduction of a multi-tier foreign exchange system implemented during the first quarter of 2014 (discussed below), described in Note 14 to the Condensed Consolidated Financial Statements.

During the first quarter of 2014, the Venezuelan government enacted several changes to Venezuela’s foreign exchange regime, introducing a multi-tier foreign exchange system whereby there are now three exchange rate mechanisms available to convert Venezuelan bolivares to U.S. dollars. The Venezuelan government replaced CADIVI with a new foreign currency administration, the National Center for Foreign Commerce (“CENCOEX”). Although the official exchange rate remains at 6.30 bolivares per dollar, the exchange rate for foreign investments moved to the rate available on the SICAD I (Supplementary System for the Administration of Foreign Currency) currency market which, in the last auction during the first quarter of 2014, was 10.70 bolivares per dollar. As part of the changes in Venezuela’s foreign exchange system enacted in the first quarter of 2014, the Venezuelan government also introduced an alternative currency market known as SICAD II.

The Company remeasures the financial statements of CP Venezuela at the end of each month at the rate at which it expects to remit future dividends which, based on the advice of legal counsel, is the SICAD I rate. Effective with the quarter ended March 31, 2014, the Company remeasured the majority of CP Venezuela’s local currency-denominated net monetary assets at the quarter-end SICAD I rate (the “2014 Remeasurement”) and incurred a pretax loss of $266 ($174 aftertax loss or $0.19 per diluted common share). Included in the loss is a charge related to the devaluation-protected bonds issued by the Venezuelan government and held by CP Venezuela. Because the official exchange rate remains at 6.30 bolivares per dollar, the devaluation-protected bonds did not revalue at the rate available on the SICAD I currency market but remained at the official exchange rate. CP Venezuela continues to be able to settle certain of its U.S. dollar obligations for imported materials at the official rate of 6.30 bolivares per dollar and records the gains related to such transactions when the funds are authorized by CENCOEX and the liabilities are paid.

There will be ongoing impacts primarily related to the translation of the local financial statements and, to a lesser degree, the import of materials at the SICAD I exchange rate as some imports may still qualify for the official rate. Based on this assumption and the SICAD I rate at the quarter-end rate of 10.70 bolivares per dollar, the Company estimates that the ongoing impacts would be approximately $0.03 per diluted common share per quarter during 2014. Because the SICAD I market is auction-based and auctions are held periodically during each quarter, the exchange rate available through SICAD I may vary throughout the year which would cause additional remeasurements of CP Venezuela’s local currency-denominated net monetary assets and further impact CP Venezuela’s ongoing results.

As part of the announcements during the first quarter of 2014, the Venezuelan government also issued a new Law on Fair Pricing, establishing a maximum profit margin of 30%. At this time, it is unclear based on the current regulations how this new law may affect CP Venezuela and its current pricing structure and, as a result, its impact is not included in the range of estimated ongoing impacts outlined above.

In the first quarter of 2013, the Company incurred a pretax loss of $172 ($111 aftertax loss) related to the remeasurement of the net monetary assets in the local balance sheet at the date of the devaluation that changed the official exchange rate from 4.30 to 6.30 bolivares per dollar (the “2013 Remeasurement”). The 2014 Remeasurement and the 2013 Remeasurement are referred to together as the “Venezuela Remeasurements.”

24

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

CP Venezuela funds its requirements for imported goods primarily through a combination of U.S. dollars obtained from CENCOEX and intercompany borrowings. CP Venezuela’s supply of U.S. dollars to fund imports has been limited and sporadic. Both the SICAD I and SICAD II currency markets are expected to be accessible to the Company, however the Company has not participated in either currency market through March 31, 2014. CP Venezuela’s difficulty in accessing U.S. dollars to support its operations has had and is expected to continue to have an adverse effect on the business. Additionally, at times, production at CP Venezuela has also been negatively impacted by labor issues within the country.

At March 31, 2014, CP Venezuela’s local currency-denominated net monetary asset position, which would be subject to remeasurement in the event of further changes in the SICAD I rate, was approximately $489. This amount includes the devaluation-protected bonds issued by the Venezuelan government. CP Venezuela’s local currency-denominated non-monetary assets were approximately $337 at March 31, 2014 and included approximately $226 of fixed assets that could be subject to impairment if CP Venezuela continues to be unable to implement price increases to offset the impacts of continued high inflation or further devaluations, or if it does not have sufficient access to U.S. dollars to fund imports. For the quarter ended March 31, 2014, CP Venezuela represented approximately 3% of the Company’s consolidated Net sales. CP Venezuela incurred a small operating loss for the quarter ended March 31, 2014, which was insignificant in relation to the Company’s consolidated Operating profit.

The Company’s business in Venezuela, and the Company’s ability to repatriate its earnings, continue to be negatively affected by these difficult conditions and would be further negatively affected by additional devaluations or the imposition of additional or more stringent controls on foreign currency exchange, pricing, payments, profits or imports or other governmental actions or continued or increased labor unrest. The Company continues to actively manage its investment in and exposure to Venezuela.

In the fourth quarter of 2012, the Company commenced a four-year Global Growth and Efficiency Program (the “2012 Restructuring Program”) for sustained growth. The program’s initiatives are expected to help Colgate ensure continued solid worldwide growth in unit volume, organic sales and earnings per share and enhance its global leadership positions in its core businesses. Implementation of the 2012 Restructuring Program, which is expected to be substantially completed by December 31, 2016, is projected to result in cumulative pretax charges, once all phases are approved and implemented, totaling between $1,100 and $1,250 ($775 and $875 aftertax). Savings, substantially all of which are expected to increase future cash flows, are projected to be in the range of $365 to $435 pretax ($275 to $325 aftertax) annually by the fourth year of the program. For more information regarding the 2012 Restructuring Program, see “Restructuring and Related Implementation Charges” below.

In the first quarter of 2014, the Company incurred aftertax costs of $73 associated with the 2012 Restructuring Program and aftertax costs of $1 related to the sale of land in Mexico.

On September 13, 2011, the Company’s Mexican subsidiary entered into an agreement to sell to the United States of America the Mexico City site on which its commercial operations, technology center and soap production facility are located. The sale price is payable in three installments, with the final installment due upon the transfer of the property, which is expected to occur in 2014. The Company is re-investing these payments to relocate its soap production to a new state-of-the-art facility at its Mission Hills, Mexico site, to relocate its commercial and technology operations within Mexico City and to prepare the existing site for transfer. Exit costs incurred during the project primarily relate to staff leaving indemnities, accelerated depreciation and demolition to make the site building-ready.

25

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

Looking forward, the Company expects global macroeconomic and market conditions to remain highly challenging. While the global marketplace in which the Company operates has always been highly competitive, the Company continues to experience heightened competitive activity in certain markets from local competitors and other large multinational companies, some of which have greater resources than the Company does. Such activities have included more aggressive product claims and marketing challenges, as well as increased promotional spending and geographic expansion. Additionally, the Company continues to experience volatile foreign currency fluctuations and high commodity costs. While the Company has taken, and will continue to take, measures to mitigate the effect of these conditions, should they persist, they could adversely affect the Company’s future results.

The Company believes it is well prepared to meet the challenges ahead due to its strong financial condition, experience operating in challenging environments and continued focus on the Company’s strategic initiatives: engaging to build our brands; innovation for growth; effectiveness and efficiency; and leading to win. This focus, together with the strength of the Company’s global brand names, its broad international presence in both mature and emerging markets and initiatives such as the 2012 Restructuring Program, should position the Company well to increase shareholder value over the long-term.

26

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

Results of Operations

Three Months

Worldwide Net sales were $4,325 in the first quarter of 2014, even with the year ago quarter, as volume growth of 5.0% and net selling price increases of 1.5% were offset by negative foreign exchange of 6.5%. Organic sales (Net sales excluding the impact of foreign exchange, acquisitions and divestments), a non-GAAP financial measure as discussed below, increased 6.5% in the first quarter of 2014.

Net sales in the Oral, Personal and Home Care segment were $3,772 in the first quarter of 2014, even with the year ago quarter, as volume growth of 5.0% and net selling price increases of 1.5% were offset by negative foreign exchange of 6.5%. Organic sales in the Oral, Personal and Home Care segment increased 6.5% in the first quarter of 2014.

The increase in organic sales in the first quarter of 2014 versus the first quarter of 2013 was driven by an increase in Oral Care sales, with the toothpaste, manual toothbrush and mouthwash categories all contributing to growth. Home Care also contributed to organic sales growth due to strong sales in the fabric softener category.

The Company’s share of the global toothpaste market was 44.3% on a year-to-date basis and its share of the global manual toothbrush market was 33.1% on a year-to-date basis. Year-to-date market shares in toothpaste were up in Europe/South Pacific and down in North America, Latin America, Asia and Africa/Eurasia versus the year ago period. In the manual toothbrush category, year-to-date market shares were up in North America and Asia, flat in Europe/South Pacific and down in Latin America and Africa/Eurasia versus the year ago period. For additional information regarding market shares, see “Market Share Information” below.

Net sales for Hill’s Pet Nutrition increased 3.5% in the first quarter of 2014 to $553, as volume growth of 3.5% and net selling price increases of 2.0% were partially offset by negative foreign exchange of 2.0%. Organic sales in Hill’s Pet Nutrition increased 5.5% in the first quarter of 2014. 

Gains in the Prescription Diet, Advanced Nutrition and Naturals categories contributed to organic sales growth for Hill’s Pet Nutrition.

Gross Profit/Margin

Worldwide Gross profit increased to $2,524 in the first quarter of 2014 from $2,515 in the first quarter of 2013. 

Gross profit in both periods included charges related to the 2012 Restructuring Program and costs related to the sale of land in Mexico. Excluding the items described above in both periods, Gross profit increased to $2,535 in the first quarter of 2014 from $2,527 in the first quarter of 2013 due to sales growth.

Worldwide Gross profit margin increased to 58.4% in the first quarter of 2014 from 58.3% in the first quarter of 2013.  Excluding the items described above, Gross profit margin was 58.6% in the first quarter of 2014, even with the year ago quarter, as higher pricing (50 bps), cost savings from the Company’s funding-the-growth initiatives (120 bps) and cost savings from the 2012 Restructuring Program (20 bps) were offset by higher raw and packaging material costs (200 bps), which included foreign exchange transaction costs.

	Three Months Ended March 31,
	2014		2013
Gross profit, GAAP	$	2,524	$	2,515
2012 Restructuring Program	10		8
Costs related to the sale of land in Mexico	1		4
Gross profit, non-GAAP	$	2,535	$	2,527

27

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

	Three Months Ended March 31,
	2014		2013		Basis Point Change
Gross profit margin, GAAP	58.4	%	58.3	%	10
2012 Restructuring Program	0.2		0.2
Costs related to the sale of land in Mexico	—		0.1
Gross profit margin, non-GAAP	58.6	%	58.6	%	—

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased 1% to $1,544 in the first quarter of 2014 from $1,536 in the first quarter of 2013. 

Selling, general and administrative expenses in both periods included charges associated with the 2012 Restructuring Program. Excluding these charges, Selling, general and administrative expenses were $1,527 in the first quarter of 2014, even with the year ago quarter, reflecting lower overhead expenses of $8 and increased advertising investment of $7.

Selling, general and administrative expenses as a percentage of Net sales increased to 35.7% in the first quarter of 2014 from 35.6% in the first quarter of 2013. Excluding charges associated with the 2012 Restructuring Program, Selling, general and administrative expenses as a percentage of Net sales were 35.3% in the first quarter of 2014, a decrease of 10 bps as compared to the first quarter of 2013. This decrease was a result of lower overhead expenses (30 bps), partially offset by increased advertising investment (20 bps), both as a percentage of Net sales. In the first quarter of 2014, advertising investment increased 1.5% to $478, as compared with $471 in the first quarter of 2013, and increased as a percentage of Net sales to 11.1% in the first quarter of 2014 from 10.9% in the first quarter of 2013.

	Three Months Ended March 31,
	2014			2013
Selling, general and administrative expenses, GAAP	$	1,544		$	1,536
2012 Restructuring Program	(17		)	(8		)
Selling, general and administrative expenses, non-GAAP	$	1,527		$	1,528

	Three Months Ended March 31,
	2014		2013		Basis Point Change
Selling, general and administrative expenses as a percentage of Net sales, GAAP	35.7	%	35.6	%	10
2012 Restructuring Program	(0.4	)	(0.2	)
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP	35.3	%	35.4	%	(10	)

28

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

Other (Income) Expense, Net

Other (income) expense, net was $346 in the first quarter of 2014, as compared to $237 in the first quarter of 2013. Other (income) expense, net in both periods included charges related to the 2012 Restructuring Program and charges related to the Venezuela Remeasurements. Other (income) expense, net in the first quarter of 2013 also included costs related to the sale of land in Mexico. Excluding these charges, Other (income) expense, net decreased to $5 in the first quarter of 2014 from $14 in the first quarter of 2013.

	Three Months Ended March 31,
	2014			2013
Other (income) expense, net, GAAP	$	346		$	237
2012 Restructuring Program	(75		)	(50		)
Venezuela Remeasurement charges	(266		)	(172		)
Costs related to the sale of land in Mexico	—			(1		)
Other (income) expense, net, non-GAAP	$	5		$	14

Operating Profit

Operating profit decreased 15% to $634 in the first quarter of 2014 from $742 in the first quarter of 2013.

Operating profit in both periods included charges associated with the 2012 Restructuring Program, charges related to the Venezuela Remeasurements and costs related to the sale of land in Mexico. Excluding the items described above in both periods, Operating profit increased 2% to $1,003 in the first quarter of 2014 from $985 in the first quarter of 2013, partially due to sales growth.

Operating profit margin was 14.7% in the first quarter of 2014, a decrease of 250 bps compared to the first quarter of 2013. Excluding the items described above in both periods, Operating profit margin increased 40 bps to 23.2% in the first quarter of 2014 as compared to 22.8% in the first quarter of 2013. A decrease in Selling, general and administrative expenses as a percentage of Net sales (10 bps), contributed to the increase in Operating profit margin.

	Three Months Ended March 31,
	2014		2013		% Change
Operating profit, GAAP	$	634	$	742	(15	)%
2012 Restructuring Program	102		66
Venezuela Remeasurement charges	266		172
Costs related to the sale of land in Mexico	1		5
Operating profit, non-GAAP	$	1,003	$	985	2	%

	Three Months Ended March 31,
	2014		2013		Basis Point Change
Operating profit margin, GAAP	14.7	%	17.2	%	(250	)
2012 Restructuring Program	2.3		1.5
Venezuela Remeasurement charges	6.2		4.0
Costs related to the sale of land in Mexico	—		0.1
Operating profit margin, non-GAAP	23.2	%	22.8	%	40

29

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

Interest (Income) Expense, Net

Interest (income) expense, net was $7 for the three months ended March 31, 2014 as compared with ($3) in the comparable period of 2013, primarily due to higher debt levels as a result of the debt issuance in the first quarter of 2014 and lower interest income on investments held outside the United States.

Income taxes

The effective tax rate was 31.1% for the first quarter of 2014 as compared to 32.1% for the first quarter of 2013. The quarterly provision for income taxes is determined based on the Company’s estimated full year effective tax rate adjusted by the amount of tax attributable to infrequent and unusual items that are separately recognized on a discrete basis in the income tax provision in the quarter in which they occur. The Company’s current estimate of its full year effective income tax rate before discrete period items is 31.7%, compared to 32.0% in the first quarter of 2013. As reflected in the table below, the non-GAAP effective income tax rate was 31.7% for the three months ended March 31, 2014 as compared to 32.0% in the comparable period of 2013.

	Three Months Ended March 31,
	2014		2013
Effective tax rate, GAAP	31.1	%	32.1	%
2012 Restructuring Program	(0.4	)	(0.9	)
Venezuela Remeasurement charges	1.0		0.8
Costs related to the sale of land in Mexico	—		—
Effective tax rate, non-GAAP	31.7	%	32.0	%

Net Income attributable to Colgate-Palmolive Company and Earnings per share

Net income attributable to Colgate-Palmolive Company for the first quarter of 2014 decreased to $388 from $460 in the first quarter of 2013, and Earnings per common share on a diluted basis decreased to $0.42 per share in the first quarter of 2014 from $0.48 per share in the first quarter of 2013. Net income attributable to Colgate-Palmolive Company in both periods included charges associated with the 2012 Restructuring Program, charges related to the Venezuela Remeasurements and costs related to the sale of land in Mexico.

Excluding the items described above, Net income attributable to Colgate-Palmolive Company in the first quarter of 2014 increased 2% to $636 and Earnings per common share on a diluted basis increased 3% to $0.68.

	Three Months Ended March 31,
	2014		2013		% Change
Net income attributable to Colgate-Palmolive Company, GAAP	$	388	$	460	(16	)%
2012 Restructuring Program	73		52
Venezuela Remeasurement charges	174		111
Costs related to the sale of land in Mexico	1		3
Net income attributable to Colgate-Palmolive Company, non-GAAP	$	636	$	626	2	%

30

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

	Three Months Ended March 31,
	2014		2013		% Change
Earnings per common share, diluted, GAAP	$	0.42	$	0.48	(13	)%
2012 Restructuring Program	0.07		0.06
Venezuela Remeasurement charges	0.19		0.12
Costs related to the sale of land in Mexico	—		—
Earnings per common share, diluted, non-GAAP	$	0.68	$	0.66	3	%

Net Sales and Operating Profit by Segment

Oral, Personal and Home Care

North America

	Three Months Ended March 31,
	2014			2013			Change
Net sales	$	785		$	764		2.5		%
Operating profit	$	216		$	215		—		%
% of Net sales	27.5		%	28.1		%	(60	)	bps

Net sales in North America increased 2.5% in the first quarter of 2014 to $785, driven by volume growth of 4.5%, which was partially offset by net selling price decreases of 1% due to increased promotional activities and negative foreign exchange of 1%. Organic sales in North America increased 3.5% in the first quarter of 2014.

The increase in organic sales in North America in the first quarter of 2014 versus the first quarter of 2013 was due to an increase in Oral Care, Personal Care and Home care sales. In Oral Care, strong sales in the toothbrush and mouthwash categories were partially offset by sales declines in the toothpaste category. Personal Care and Home Care organic sales growth were driven by gains in the underarm protection and hand dish categories, respectively.

Operating profit in North America was $216 in the first quarter of 2014, even with the year ago quarter, while as a percentage of Net sales it decreased 60 bps to 27.5%. This decrease in Operating profit as a percentage of Net sales was primarily due to a decrease in Gross profit (50 bps) and an increase in Selling, general and administrative expenses (30 bps), both as a percentage of Net sales. This decrease in Gross profit was primarily due to higher raw and packaging material costs (110 bps) and pricing as noted above, which were partially offset by cost savings from the Company’s funding-the-growth initiatives (110 bps). This increase in Selling, general and administrative expenses was driven by increased advertising investment (130 bps), which was partially offset by lower overhead expenses (100 bps).

31

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

Latin America

	Three Months Ended March 31,
	2014			2013			Change
Net sales	$	1,152		$	1,214		(5.0	)	%
Operating profit	$	290		$	312		(7	)	%
% of Net sales	25.2		%	25.7		%	(50	)	bps

Net sales in Latin America decreased 5.0% to $1,152 in the first quarter of 2014. Volume growth of 4.5% and net selling price increases of 6.5% were more than offset by negative foreign exchange of 16.0%. Organic sales in Latin America increased 11.0% in the first quarter of 2014. Volume gains were led by Venezuela, Brazil, Mexico and Colombia.

The increase in organic sales in Latin America in the first quarter of 2014 versus the first quarter of 2013 was driven by an increase in Oral Care sales with the toothpaste, manual toothbrush and mouthwash categories all contributing to growth. Home Care also contributed to organic sales growth due to strong sales in the fabric softener and hand dish categories.

Operating profit in Latin America decreased 7% in the first quarter of 2014 to $290, or 50 bps to 25.2% of Net sales. This decrease in Operating profit was primarily due to a decrease in Gross profit (140 bps), which was partially offset by a decrease in Selling, general and administrative expenses (70 bps), both as a percentage of Net sales. This decrease in Gross profit was due to higher costs (490 bps), including higher costs in Venezuela due to inflation and the impact of charging Cost of sales, as required, with the historical U.S. dollar cost of inventory acquired prior to the effective devaluation. This decrease was partially offset by cost savings from the Company’s funding-the-growth initiatives (120 bps) and pricing as noted above. This decrease in Selling, general and administrative expenses was due to lower overhead expenses (40 bps) and decreased advertising investment (30 bps).

Europe/South Pacific

	Three Months Ended March 31,
	2014			2013			Change
Net sales	$	865		$	848		2.0	%
Operating profit	$	217		$	200		9	%
% of Net sales	25.1		%	23.6		%	150	bps

Net sales in Europe/South Pacific increased 2.0% in the first quarter of 2014 to $865. Volume growth of 3.5% and positive foreign exchange of 1.0% were partially offset by net selling price decreases of 2.5% due to increased promotional activities. Organic sales in Europe/South Pacific increased 1.5% in the first quarter of 2014. Volume gains were led by Australia, Poland, France and the United Kingdom.

The increase in organic sales in Europe/South Pacific in the first quarter of 2014 versus the first quarter of 2013 was due to higher Oral Care sales, which were partially offset by declines in sales in the Home Care category. The toothpaste category contributed to the increase in Oral Care sales. The decrease in Home Care sales was due to sales declines in the liquid cleaners category.

Operating profit in Europe/South Pacific increased 9% in the first quarter of 2014 to $217, or 150 bps to 25.1% of Net sales. This increase in Operating profit was primarily due to an increase in Gross profit (220 bps), which was partially offset by an increase in Selling, general and administrative expenses (30 bps), both as a percentage of Net sales. This increase in Gross profit was primarily driven by cost savings from the Company’s funding-the-growth initiatives (130 bps), cost savings from the Company’s 2012 Restructuring Program (70 bps) and lower raw and packaging material costs (60 bps), which were partially offset by pricing as noted above. This increase in Selling, general and administrative expenses was driven by increased advertising investment (40 bps), which was partially offset by lower overhead expenses (10 bps).

32

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

Asia

	Three Months Ended March 31,
	2014			2013			Change
Net sales	$	672		$	655		2.5	%
Operating profit	$	193		$	186		4	%
% of Net sales	28.7		%	28.4		%	30	bps

Net sales in Asia increased 2.5% in the first quarter of 2014 to $672 driven by volume growth of 7.0% and net selling price increases of 0.5%, which were partially offset by negative foreign exchange of 5.0%. Organic sales in Asia grew 7.5% in the first quarter of 2014. Volume gains were led by the Greater China region, India, the Philippines and Malaysia.

The increase in organic sales in the first quarter of 2014 versus the first quarter of 2013 was driven by an increase in Oral Care sales with the toothpaste and manual toothbrush categories contributing to growth. Personal Care sales also contributed to organic sales growth with gains in the shampoo category.

Operating profit in Asia increased 4% in the first quarter of 2014 to $193, or 30 bps to 28.7% of Net sales. This increase in Operating profit was primarily due to an increase in Gross profit margin (10 bps), as Selling, general and administrative expenses as a percentage of Net sales were flat. This increase in Gross profit was primarily due to cost savings from the Company’s funding-the-growth initiatives (90 bps) and pricing as noted above, partially offset by higher raw and packaging material costs (100 bps), which included foreign exchange transaction costs.

Africa/Eurasia

	Three Months Ended March 31,
	2014			2013			Change
Net sales	$	298		$	300		(0.5	)	%
Operating profit	$	59		$	62		(5	)	%
% of Net sales	19.8		%	20.7		%	(90	)	bps

Net sales in Africa/Eurasia decreased 0.5% in the first quarter of 2014 to $298. Volume growth of 9.5% and net selling price increases of 0.5% were more than offset by negative foreign exchange of 10.5%. Organic sales in Africa/Eurasia grew 10.0% in the first quarter of 2014. Volume gains were led by Turkey, Russia, the Central Asia/Caucasus region and South Africa.

The increase in organic sales in the first quarter of 2014 versus the first quarter of 2013 was driven by an increase in Oral Care sales due to strong sales in the toothpaste category. Personal Care sales also contributed to organic sales growth with gains in the shower gel category.

Operating profit in Africa/Eurasia decreased 5% in the first quarter of 2014 to $59, or 90 bps to 19.8% of Net sales. This decrease in Operating profit was due to a decrease in Gross profit (130 bps), which was partially offset by a decrease in Selling, general and administrative expenses (30 bps), both as a percentage of Net sales. This decrease in Gross profit was primarily due to higher raw and packaging material costs (360 bps), which included foreign exchange transaction costs, partially offset by cost savings from the Company’s funding-the-growth initiatives (90 bps) and pricing as noted above. This decrease in Selling, general and administrative expenses was due to decreased advertising investment (30 bps).

33

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

Hill’s Pet Nutrition

	Three Months Ended March 31,
	2014			2013			Change
Net sales	$	553		$	534		3.5	%
Operating profit	$	144		$	136		6	%
% of Net sales	26.0		%	25.5		%	50	bps

Net sales for Hill’s Pet Nutrition increased 3.5% in the first quarter of 2014 to $553, driven by volume growth of 3.5% and net selling price increases of 2.0%, which were partially offset by negative foreign exchange of 2.0%. Organic sales in Hill’s Pet Nutrition increased 5.5% in the first quarter of 2014. Volume gains in Japan, Russia, the United States and France were partially offset by volume declines in Canada. The volume gains in Japan were due to timing of customer shipments.

The increase in organic sales in the first quarter of 2014 versus the first quarter of 2013 was driven by continued growth in the Prescription Diet category. The Advanced Nutrition and Naturals categories also contributed to organic sales growth.

Operating profit in Hill’s Pet Nutrition increased 6% in the first quarter of 2014 to $144, or 50 bps to 26.0% of Net sales. This increase in Operating profit was primarily due to a decrease in Selling, general and administrative expenses (30 bps) and Other (income) expense, net (100 bps), which were partially offset by a decrease in Gross profit (80 bps), all as a percentage of Net sales. This decrease in Gross profit was primarily driven by higher raw and packaging material costs (260 bps), due in part to formulation changes and foreign exchange transaction costs, which were partially offset by cost savings from the Company’s funding-the-growth initiatives (140 bps) and pricing as noted above. This decrease in Selling, general and administrative expenses was due to decreased advertising investment (150 bps), which was partially offset by higher overhead expenses, due to increased investment in customer development initiatives (120 bps). This decrease in Other (income) expense, net was primarily due to the expiration of a third party royalty agreement.

Corporate

	Three Months Ended March 31,
	2014			2013			Change
Operating profit (loss)	$	(485	)	$	(369	)	31	%

Operating profit (loss) related to Corporate was ($485) in the first quarter of 2014 as compared to ($369) in the first quarter of 2013. In the first quarter of 2014, Corporate Operating profit (loss) included charges of $102 associated with the 2012 Restructuring Program, a charge of $266 related to the 2014 Remeasurement and costs of $1 related to the sale of land in Mexico. In the first quarter of 2013, Corporate Operating profit (loss) included charges of $66 associated with the 2012 Restructuring Program, a charge of $172 related to the 2013 Remeasurement and costs of $5 related to the sale of land in Mexico.

34

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

Restructuring and Related Implementation Charges

2012 Restructuring Program

In the fourth quarter of 2012, the Company commenced a four-year Global Growth and Efficiency Program for sustained growth. The program’s initiatives are expected to help Colgate ensure continued solid worldwide growth in unit volume, organic sales and earnings per share and enhance its global leadership positions in its core businesses.

The 2012 Restructuring Program is expected to produce significant benefits in the Company’s long-term business performance. The major objectives of the program include:

▪ Becoming even stronger on the ground through the continued evolution and expansion of proven global and regional commercial capabilities, which have already been successfully implemented in a number of the Company’s operations around the world.

▪ Simplifying and standardizing how work gets done by increasing technology-enabled collaboration and taking advantage of global data and analytic capabilities, leading to smarter and faster decisions.

▪ Reducing structural costs to continue to increase the Company’s gross and operating profit.

▪ Building on Colgate’s current position of strength to enhance its leading market share positions worldwide and ensure sustained sales and earnings growth.

Implementation of the 2012 Restructuring Program is projected to result in cumulative pretax charges, once all phases are approved and implemented, totaling between $1,100 and $1,250 ($775 and $875 aftertax), which are currently estimated to be comprised of the following categories: Employee-Related Costs, including severance, pension and other termination benefits (50%); asset-related costs, primarily Incremental Depreciation and Asset Impairments (15%); and Other charges, which include contract termination costs, consisting primarily of implementation-related charges resulting directly from exit activities (20%) and the implementation of new strategies (15%). Anticipated pretax charges for 2014 are expected to amount to approximately $275 to $325 ($200 to $230 aftertax). Over the course of the 2012 Restructuring Program, it is estimated that approximately 75% of the charges will result in cash expenditures.

It is expected that the cumulative pretax charges, once all projects are approved and implemented, will relate to initiatives undertaken in North America (15%), Europe/South Pacific (20%), Latin America (5%), Asia (5%), Africa/Eurasia (5%), Hill’s Pet Nutrition (10%) and Corporate (40%), which includes substantially all of the costs related to the implementation of new strategies, noted above, on a global basis. It is expected that by the end of 2016, the 2012 Restructuring Program will reduce the Company’s global employee workforce by approximately 6% from the 2012 level of approximately 38,000.

Savings, substantially all of which are expected to increase future cash flows, are projected to be in the range of $365 to $435pretax ($275 to $325 aftertax) annually by the fourth year of the program. Savings in 2014 should approximate $105 to $125 ($90 to $110 aftertax).

Initiatives under the program are focused on the following three areas:

▪ Expanding Commercial Hubs - Building on the success of this structure already implemented in several divisions, continuing to cluster single-country subsidiaries into more efficient regional hubs, in order to drive smarter and faster decision making, strengthen capabilities available on the ground and improve cost structure.

▪ Extending Shared Business Services and Streamlining Global Functions - Implementing the Company’s shared service organizational model, already successful in Europe, in all regions of the world. Initially focused on finance and accounting, these shared services will be expanded to additional functional areas to streamline global functions.

▪ Optimizing Global Supply Chain and Facilities - Continuing to optimize manufacturing efficiencies, global warehouse networks and office locations for greater efficiency, lower cost and speed to bring innovation to market.

35

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

For the three months ended March 31, 2014 and 2013, restructuring and implementation-related charges are reflected in the income statement as follows:

	Three Months Ended March 31,
	2014		2013
Cost of sales	$	10	$	8
Selling, general and administrative expenses	17		8
Other (income) expense, net	75		50
Total 2012 Restructuring Program charges, pretax	$	102	$	66
Total 2012 Restructuring Program charges, aftertax	$	73	$	52

Restructuring and related implementation charges in the preceding table are recorded in the Corporate segment as these initiatives are predominantly centrally directed and controlled and are not included in internal measures of segment operating performance. Total charges for the 2012 Restructuring Program for the three months endedMarch 31, 2014 relate to initiatives undertaken in North America (9%), Europe/South Pacific (21%), Latin America (4%), Africa/Eurasia (2%), Hill’s Pet Nutrition (8%) and Corporate (56%). Total charges for the 2012 Restructuring Program for the three months endedMarch 31, 2013 relate to initiatives undertaken in Europe/South Pacific (31%), Latin America (15%), Africa/Eurasia (6%), Hill’s Pet Nutrition (3%) and Corporate (45%). Total program-to-date accumulated charges for the 2012 Restructuring Program relate to initiatives undertaken in North America (10%), Europe/South Pacific (31%), Latin America (3%), Africa/Eurasia (5%), Hill’s Pet Nutrition (7%) and Corporate (44%).

Since the inception of the 2012 Restructuring Program in the fourth quarter of 2012, the Company has incurred pretax cumulative charges of $562 ($421 aftertax) in connection with the implementation of various projects as follows:

	Cumulative Charges
	as of March 31, 2014
Employee-Related Costs	$	242
Incremental Depreciation	32
Asset Impairments	1
Other	287
Total	$	562

The majority of costs incurred since inception relate to the following projects: restructuring how the Company provides retirement benefits to its U.S.-based employees by shifting them from the Company’s defined benefit retirement plan to the Company’s defined contribution plan; the closing of the Morristown, New Jersey personal care facility; the simplification and streamlining of the Company’s research and development capabilities and oral care supply chain, both in Europe; the consolidation of facilities; the implementation of the Company’s hubbing strategy in Europe; and the extension of shared business services and streamlining global functions.

36

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

The following table summarizes the activity for the restructuring and implementation-related charges discussed above and the related accruals:

	Three Months Ended March 31, 2014
	Employee-Related Costs			Incremental Depreciation			Asset Impairments		Other			Total
Balance at December 31, 2013	$	116		$	—		$	—	$	42		$	158
Charges	20			6			—		76			102
Cash payments	(31		)	—			—		(23		)	(54		)
Charges against assets	(1		)	(6		)	—		—			(7		)
Foreign exchange	(1		)	—			—		(1		)	(2		)
Balance at March 31, 2014	$	103		$	—		$	—	$	94		$	197

Employee-Related Costs primarily include severance and other termination benefits and are calculated based on long-standing benefit practices, local statutory requirements and, in certain cases, voluntary termination arrangements. Employee-Related Costs also include pension enhancements amounting to $1 for the three months ended March 31, 2014, which are reflected as Charges against assets within Employee-Related Costs in the preceding tables as the corresponding balance sheet amounts are reflected as a reduction of pension assets or an increase in pension liabilities.

Incremental Depreciation is recorded to reflect changes in useful lives and estimated residual values for long-lived assets that will be taken out of service prior to the end of their normal service period. Asset Impairments are recorded to write down assets held for sale or disposal to their fair value based on amounts expected to be realized. Charges against assets within Asset Impairments are net of cash proceeds pertaining to the sale of certain assets.

Other charges consist primarily of charges resulting directly from exit activities and the implementation of new strategies as a result of the 2012 Restructuring Program. These charges for the three months ended March 31, 2014 included third-party incremental costs related to the development and implementation of new business and strategic initiatives of $16 and contract termination costs and charges resulting directly from exit activities of $21 directly related to the 2012 Restructuring Program. These charges were expensed as incurred. Also included in Other charges for the three months ended March 31, 2014 are other exit costs related to the consolidation of facilities of $39.

37

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

Non-GAAP Financial Measures

This Quarterly Report on Form 10-Q discusses organic sales growth (Net sales growth excluding the impact of foreign exchange, acquisitions and divestments) (non-GAAP). Management believes this measure provides investors with useful supplemental information regarding the Company’s underlying sales trends by presenting sales growth excluding the external factor of foreign exchange, as well as the impact of acquisitions and divestments. A reconciliation of organic sales growth to Net sales growth for the three-months ended March 31, 2014 is provided below.

Worldwide Gross profit, Gross profit margin, Selling, general and administrative expenses, Selling, general and administrative expenses as a percentage of Net sales, Other (income) expense, net, Operating profit, Operating profit margin, effective tax rate, Net income attributable to Colgate-Palmolive Company and Earnings per share on a diluted basis are discussed in this Quarterly Report on Form 10-Q both on a GAAP basis and, as applicable, excluding charges related to the 2012 Restructuring Program, charges related to the Venezuela Remeasurements and costs related to the sale of land in Mexico (non-GAAP). Management believes these non-GAAP financial measures provide investors with useful supplemental information regarding the performance of the Company’s ongoing operations. A reconciliation of each of these non-GAAP financial measures to the most directly comparable GAAP financial measures for the three months endedMarch 31, 2014 and 2013 is presented within the applicable section of Results of Operations.

The Company uses the above financial measures internally in its budgeting process and as a factor in determining compensation. While the Company believes that these non-GAAP financial measures are useful in evaluating the Company’s business, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. In addition, these non-GAAP financial measures may not be the same as similar measures presented by other companies.

The following table provides a quantitative reconciliation of organic sales growth to Net sales growth for the three months endedMarch 31, 2014.

Three months ended March 31, 2014	Organic Sales Growth (Non-GAAP)	Foreign Exchange Impact	Acquisitions and Divestments Impact	Net Sales Growth (GAAP)
Oral, Personal and Home Care
North America	3.5%	(1.0)%	0.0%	2.5%
Latin America	11.0%	(16.0)%	0.0%	(5.0)%
Europe/South Pacific	1.5%	1.0%	(0.5)%	2.0%
Asia	7.5%	(5.0)%	0.0%	2.5%
Africa/Eurasia	10.0%	(10.5)%	0.0%	(0.5)%
Total Oral, Personal and Home Care	6.5%	(6.5)%	0.0%	0.0%
Pet Nutrition	5.5%	(2.0)%	0.0%	3.5%
Total Company	6.5%	(6.5)%	0.0%	0.0%

38

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

Liquidity and Capital Resources

The Company expects cash flow from operations and debt issuances will be sufficient to meet foreseeable business operating and recurring cash needs (including for debt service, dividends, capital expenditures, costs associated with the 2012 Restructuring Program and stock repurchases). The Company believes its strong cash generation and financial position should continue to allow it broad access to global credit and capital markets.

Net cash provided by operations increased 6% to $820 in the first three months of 2014, compared with $777 in the comparable period of 2013 due to strong operating earnings and a continued tight focus on working capital.

The Company defines working capital as the difference between current assets (excluding Cash and cash equivalents and marketable securities, the latter of which is reported in Other current assets) and current liabilities (excluding short-term debt). Overall, the Company’s working capital decreased to (0.8%) of Net sales in the first three months of 2014 as compared to (0.5%) in the first three months of 2013, primarily due to an improvement in accounts receivable days sales outstanding and an increase in accounts payable and accrued liabilities, in part related to the 2012 Restructuring Program.

Approximately 75% of total program charges related to the 2012 Restructuring Program, currently estimated between $1,100 and $1,250 ($775 and $875 aftertax), are expected to result in cash expenditures. Savings are currently projected to be in the range of $365 to $435 ($275 to $325 aftertax) annually by the fourth year of the program, substantially all of which are expected to increase future cash flows. The anticipated charges for 2014 are expected to amount to approximately $275 to $325 ($200 to $230 aftertax) and savings in 2014 should approximate $105 to $125 ($90 to $110 aftertax). It is anticipated that cash requirements for the 2012 Restructuring Program will be funded from operating cash flows.

Investing activities used $249 in the first three months of 2014, compared with $232 in the comparable period of 2013. Purchases of marketable securities and investments decreased in the first three months of 2014 to $151 from $199 in the comparable period of 2013 primarily due to a decrease in the Company’s investments through its subsidiary in Venezuela in local currency denominated fixed interest rate bonds issued by the Venezuelan government. Capital spending increased in the first three months of 2014 to $168 from $94 in the comparable period of 2013. The Company continues to focus its capital spending on projects that are expected to yield high aftertax returns. Capital expenditures for 2014 are expected to remain at an annual rate of approximately 4.5% of Net sales, which is higher than the historical rate of approximately 3.5%, primarily due to the 2012 Restructuring Program.

Financing activities provided $303 of cash during the first three months of 2014 compared with a use of $462 in the comparable period of 2013, reflecting higher proceeds from the issuances of debt, partially offset by higher principal payments on debt and higher repurchases of common stock in the first three months of 2014 compared to the first three months of 2013.

Long-term debt, including the current portion, increased to $6,635 as of March 31, 2014 as compared to $5,644 as of December 31, 2013 and total debt increased to $6,659 as of March 31, 2014 as compared to $5,657 as of December 31, 2013. During the first quarter of 2014, the Company issued $500 of five-year notes at a fixed rate of 1.75% and $500 of ten-year notes at a fixed rate of 3.25%. The debt issuances were U.S. dollar denominated and were under the Company’s shelf registration statement. Proceeds from the debt issuances in the first three months of 2014 were used for general corporate purposes which included the retirement of commercial paper borrowings and will also be used to repay and retire $250 of U.S. dollar denominated notes and €250 euro denominated notes both due in the second quarter of 2014.

39

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

As of March 31, 2014, the Company had no commercial paper outstanding. Commercial paper outstanding was $627 as of March 31, 2013. The average daily balances outstanding for commercial paper in the first three months of 2014 and 2013 were $1,405 and $1,716, respectively. The Company classifies commercial paper and certain current maturities of notes payable as long-term debt when it has the intent and ability to refinance such obligations on a long-term basis, including, if necessary, by utilizing its line of credit that expires in 2018.

Certain of the facilities with respect to the Company’s bank borrowings contain financial and other covenants as well as cross-default provisions. Noncompliance with these requirements could ultimately result in the acceleration of amounts owed. The Company is in full compliance with all such requirements and believes the likelihood of noncompliance is remote.

In the first quarter of 2014, the Company increased the annualized common stock dividend by 6% to $1.44 per share, effective in the second quarter of 2014. On September 8, 2011, the Company’s Board of Directors (the “Board”) approved a share repurchase program that authorized the repurchase of up to 50 million shares of the Company’s common stock (the “2011 Program”). The Board authorized that the number of shares remaining under the 2011 Program as of May 15, 2013 be increased by 100% as a result of the two-for-one stock split in 2013.

Cash and cash equivalents increased $833 during the first three months of 2014 to $1,795 at March 31, 2014, compared to $962 at December 31, 2013, most of which ($1,707 and $865, respectively) were held by the Company’s foreign subsidiaries. These amounts include $19 and $114, respectively, which are subject to currency exchange controls in Venezuela, limiting the total amount of Cash and cash equivalents held by the Company’s foreign subsidiaries that can be repatriated at any particular point in time. The Company regularly assesses its cash needs and the available sources to fund these needs and, as part of this assessment, the Company determines the amount of foreign earnings it intends to repatriate to help fund its domestic cash needs and provides applicable U.S. income and foreign withholding taxes on such earnings.

As of December 31, 2013, the Company had approximately $4,700 of undistributed earnings of foreign subsidiaries for which no U.S. income or foreign withholding taxes have been provided as the Company does not currently anticipate a need to repatriate these earnings. These earnings have been and currently are considered to be indefinitely reinvested and, therefore, are not subject to such taxes. Should these earnings be repatriated in the future, they would be subject to applicable U.S. income and foreign withholding taxes. Determining the tax liability that would arise if these earnings were repatriated is not practicable.

For additional information regarding liquidity and capital resources, please refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2013.

Market Share Information

Management uses market share information as a key indicator to monitor business health and performance. References to market share in this Quarterly Report on Form 10-Q are based on a combination of consumption and market share data provided by third-party vendors, primarily Nielsen, and internal estimates. All market share references represent the percentage of the dollar value of sales of our products, relative to all product sales in the category in the countries in which the Company competes and purchases data.

Market share data is subject to limitations on the availability of up-to-date information. We believe that the third-party vendors we use to provide data are reliable, but we have not verified the accuracy or completeness of the data or any assumptions underlying the data. In addition, market share information calculated by the Company may be different from market share information calculated by other companies due to differences in category definitions, the use of data from different countries, internal estimates and other factors.

40

COLGATE-PALMOLIVE COMPANY

Management’s Discussion and Analysis of Financial

Condition and Results of Operations

(Dollars in Millions Except Share and Per Share Amounts)

Cautionary Statement on Forward-Looking Statements

This Quarterly Report on Form 10-Q may contain forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995 or by the SEC in its rules, regulations and releases. Such statements may relate, for example, to sales or volume growth, organic sales growth, profit or profit margin growth, earnings growth, financial goals, the impact of currency devaluations and exchange controls, price or profit controls and labor unrest, including in Venezuela, cost-reduction plans including the 2012 Restructuring Program, tax rates, new product introductions, commercial investment levels or legal proceedings, among other matters. These statements are made on the basis of the Company’s views and assumptions as of this time and the Company undertakes no obligation to update these statements, except as required by law. Moreover, the Company does not, nor does any other person, assume responsibility for the accuracy and completeness of those statements. The Company cautions investors that any such forward-looking statements are not guarantees of future performance and that actual events or results may differ materially from those statements. Actual events or results may differ materially because of factors that affect international businesses and global economic conditions, as well as matters specific to the Company and the markets it serves, including the uncertain economic environment in different countries and its effect on consumer spending habits, increased competition and evolving competitive practices, currency rate fluctuations, exchange controls, price or profit controls, labor relations, changes in foreign or domestic laws or regulations or their interpretation, political and fiscal developments, the availability and cost of raw and packaging materials, the ability to maintain or increase selling prices as needed, the ability to implement the 2012 Restructuring Program as planned or differences between the actual and the estimated costs or savings under such program, changes in the policies of retail trade customers, the ability to continue lowering costs and the uncertainty of the outcome of legal proceedings, whether or not the Company believes they have merit. For information about these and other factors that could impact the Company’s business and cause actual results to differ materially from forward-looking statements, refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2013, including the information set forth under the captions “Item 1A. Risk Factors” and “Cautionary Statement on Forward-Looking Statements.”

Quantitative and Qualitative Disclosures about Market Risk

There is no material change in the information reported under Part II, Item 7, “Managing Foreign Currency, Interest Rate, Commodity Price and Credit Risk Exposure” contained in our Annual Report on Form 10-K for the year ended December 31, 2013.

41

COLGATE-PALMOLIVE COMPANY

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

The Company’s management, under the supervision and with the participation of the Company’s Chairman of the Board, President and Chief Executive Officer and its Chief Financial Officer, carried out an evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of March 31, 2014 (the “Evaluation”). Based upon the Evaluation, the Company’s Chairman of the Board, President and Chief Executive Officer and its Chief Financial Officer concluded that the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934) are effective.

Changes in Internal Control over Financial Reporting

There were no changes in the Company’s internal control over financial reporting that occurred during the Company’s most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

42

COLGATE-PALMOLIVE COMPANY

PART II.OTHER INFORMATION

Item 1.Legal Proceedings

For information regarding legal matters, please refer to Item 3 in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013, Note 13 to the Consolidated Financial Statements included therein and Note 11 to the Condensed Consolidated Financial Statements contained in this Quarterly Report on Form 10-Q.

Item 1A.Risk Factors

For information regarding risk factors, please refer to Part 1, Item 1A in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013.

43

COLGATE-PALMOLIVE COMPANY

Item 2.Unregistered Sales of Equity Securities and Use of Proceeds

The share repurchase program approved by the Company’s Board of Directors (the “Board”) on September 8, 2011 (the “2011 Program”) authorized the repurchase of up to 50 million shares of the Company’s common stock. The Board authorized that the number of shares remaining under the 2011 Program as of May 15, 2013 be increased by 100% as a result of the two-for-one stock split in 2013. The Board also has authorized share repurchases on an ongoing basis to fulfill certain requirements of the Company’s compensation and benefit programs. The shares will be repurchased from time to time in open market or privately negotiated transactions at the Company’s discretion, subject to market conditions, customary blackout periods and other factors.

The following table shows the share repurchase activity for the three months in the quarter ended March 31, 2014:

Month	Total Number of Shares Purchased(1)	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(2)	Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs
January 1 through 31, 2014	1,290,010	$	63.78	1,263,943	24,673,619
February 1 through 28, 2014	2,981,195	$	61.53	2,480,500	22,193,119
March 1 through 31, 2014	2,479,027	$	63.52	2,364,353	19,828,766
Total	6,750,232	$	62.69	6,108,796

⁽¹⁾  Includes share repurchases under the 2011 Program and those associated with certain employee elections under the Company’s compensation and benefit programs.

⁽²⁾  The difference between the total number of shares purchased and the total number of shares purchased as part of publicly announced plans or programs is 641,436 shares, all of which relate to shares deemed surrendered to the Company to satisfy certain employee elections under its compensation and benefit programs.

Item 3.Defaults Upon Senior Securities

None.

Item 4.Mine Safety Disclosures

Not Applicable.

Item 5.Other Information

None.

44

COLGATE-PALMOLIVE COMPANY

Item 6.Exhibits

Exhibit No.	Description
12	Computation of Ratio of Earnings to Fixed Charges.
31-A	Certificate of the Chairman of the Board, President and Chief Executive Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.
31-B	Certificate of the Chief Financial Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.
32	Certificate of the Chairman of the Board, President and Chief Executive Officer and the Chief Financial Officer of Colgate-Palmolive Company pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. § 1350.
101	The following materials from Colgate-Palmolive Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2014, formatted in eXtensible Business Reporting Language (XBRL): (i) the Condensed Consolidated Statements of Income; (ii) the Condensed Consolidated Statements of Comprehensive Income; (iii) the Condensed Consolidated Balance Sheets; (iv) the Condensed Consolidated Statements of Cash Flows; and (v) Notes to Condensed Consolidated Financial Statements.

45

COLGATE-PALMOLIVE COMPANY

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	COLGATE-PALMOLIVE COMPANY
	(Registrant)
	Principal Executive Officer:
April 25, 2014	/s/ Ian Cook
	Ian Cook
	Chairman of the Board, President and Chief Executive Officer
	Principal Financial Officer:
April 25, 2014	/s/ Dennis J. Hickey
	Dennis J. Hickey
	Chief Financial Officer
	Principal Accounting Officer:
April 25, 2014	/s/ Victoria L. Dolan
	Victoria L. Dolan
	Vice President and Corporate Controller

46

EX-12

EXHIBIT 12

COLGATE-PALMOLIVE COMPANY

COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES

(Dollars in Millions Except as Indicated)

(Unaudited)

	Three Months Ended March 31, 2014
Earnings:
Income before income taxes	$	627
Add:
Fixed charges	51
Less:
Income from equity investees	(1		)
Capitalized interest	(1		)
Income as adjusted	$	676
Fixed Charges:
Interest on indebtedness and amortization of debt expense and discount or premium	$	31
Portion of rents representative of interest factor	19
Capitalized interest	1
Total Fixed Charges	$	51
Ratio of earnings to fixed charges	13.3

EX-31.A

EXHIBIT 31-A

I, Ian Cook, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Colgate-Palmolive Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 25, 2014

/s/ Ian Cook

Ian Cook

Chairman of the Board, President and

Chief Executive Officer

EX-31.B

EXHIBIT 31-B

I, Dennis J. Hickey, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Colgate-Palmolive Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 25, 2014

/s/ Dennis J. Hickey

Dennis J. Hickey

Chief Financial Officer

EX-32

EXHIBIT 32

The undersigned Chairman of the Board, President and Chief Executive Officer and Chief Financial Officer of Colgate-Palmolive Company each certify, pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. § 1350, that:

(1) the Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2014 (the “Periodic Report”) which this statement accompanies fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

(2) information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of Colgate-Palmolive Company.

Date: April 25, 2014

/s/ Ian Cook

Ian Cook

Chairman of the Board, President and

Chief Executive Officer

/s/ Dennis J. Hickey

Dennis J. Hickey

Chief Financial Officer

XML

Segment Information (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Segment Reporting Information [Line Items]
Pretax Venezuela Remeasurement Charge	$ 266	$ 172
Pretax costs related to sale of land	1	5
Total Net sales	4,325	4,315
Total Operating profit	634	742
Operating Segments [Member] | Oral, Personal and Home Care [Member]
Segment Reporting Information [Line Items]
Total Net sales	3,772	3,781
Total Operating profit	975	975
Operating Segments [Member] | Pet Nutrition [Member]
Segment Reporting Information [Line Items]
Total Net sales	553	534
Total Operating profit	144	136
Operating Segments [Member] | North America [Member] | Oral, Personal and Home Care [Member]
Segment Reporting Information [Line Items]
Total Net sales	785	764
Total Operating profit	216	215
Operating Segments [Member] | Latin America [Member] | Oral, Personal and Home Care [Member]
Segment Reporting Information [Line Items]
Total Net sales	1,152	1,214
Total Operating profit	290	312
Operating Segments [Member] | Europe/South Pacific [Member] | Oral, Personal and Home Care [Member]
Segment Reporting Information [Line Items]
Total Net sales	865	848
Total Operating profit	217	200
Operating Segments [Member] | Asia [Member] | Oral, Personal and Home Care [Member]
Segment Reporting Information [Line Items]
Total Net sales	672	655
Total Operating profit	193	186
Operating Segments [Member] | Africa/Eurasia [Member] | Oral, Personal and Home Care [Member]
Segment Reporting Information [Line Items]
Total Net sales	298	300
Total Operating profit	59	62
Corporate, Non-Segment [Member] | Corporate, Non-Segment [Member]
Segment Reporting Information [Line Items]
Total Operating profit	(485)	(369)
Two Thousand Twelve Restructuring Program [Member]
Segment Reporting Information [Line Items]
Pretax charges related to the 2012 Restructuring Program	$ 102	$ 66
Sales Revenue, Net [Member]
Segment Reporting Information [Line Items]
Percentage of Consolidated Net Sales represented by Sales outside US	80.00%
Percentage of Consolidated Net Sales coming from Emerging Markets	50.00%

XML

Inventories (Details) (USD $) In Millions, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Inventory, Net [Abstract]
Raw materials and supplies	$ 338	$ 340
Work-in-process	63	60
Finished goods	1,077	1,025
Total Inventories	$ 1,478	$ 1,425

XML

Other Comprehensive Income (Tables)

3 Months Ended

Mar. 31, 2014

Other Comprehensive Income (Loss) [Abstract]

Schedule of Comprehensive Income (Loss)

Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the three months endedMarch 31, 2014 and 2013 were as follows:

	2014						2013
	Pretax			Net of Tax			Pretax			Net of Tax
Cumulative translation adjustments	$	(39	)	$	(43	)	$	(45	)	$	(55	)
Retirement plans and other retiree benefits:
Net actuarial gain (loss) and prior service costs arising during the period	3			2			3			2
Amortization of net actuarial loss, transition and prior service costs (1)	14			11			26			18
Retirement plans and other retiree benefits adjustments	17			13			29			20
Available-for-sale securities:
Unrealized gains (losses) on available-for-sale securities (2)	(298		)	(194		)	(141		)	(90		)
Reclassification of (gains) losses into net earnings on available-for-sale securities (3)	211			138			133			86
Gains (losses) on available-for-sale securities	(87		)	(56		)	(8		)	(4		)
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges	2			1			7			5
Reclassification of (gains) losses into net earnings on cash flow hedges (4)	(3		)	(1		)	(4		)	(3		)
Gains (losses) on cash flow hedges	(1		)	—			3			2
Total Other comprehensive income (loss)	$	(110	)	$	(86	)	$	(21	)	$	(37	)

⁽¹⁾These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 10, Retirement Plans and Other Retiree Benefits for additional details.

⁽²⁾For the three months ended March 31, 2014, these amounts included pretax losses of $276 related to the remeasurement of the bolivar denominated fixed interest rate bonds and the devaluation-protected bonds in Venezuela as a result of the effective devaluation in the first quarter of 2014.

For the three months ended March 31, 2013, these amounts included pretax losses of $133 only related to the remeasurement of the bolivar denominated fixed interest rate bonds in Venezuela as a result of the devaluation in the first quarter of 2013. No remeasurement charge was required on the devaluation-protected bonds in the first quarter of 2013 since the official exchange rate changed from 4.30 to 6.30 bolivares per dollar and the devaluation-protected bonds revalued to the official exchange rate. See Note 13, Fair Value Measurements and Financial Instruments for additional details.

⁽³⁾Represents reclassification of (gains) losses on the Venezuela bonds into Other (income) expense, net due to an impairment in the fair value of the bonds as a result of the effective devaluation in the first quarter of 2014 and the devaluation in the first quarter of 2013. See Note 13, Fair Value Measurements and Financial Instruments for additional details.

⁽⁴⁾These (gains) losses are reclassified into Cost of sales. See Note 13, Fair Value Measurements and Financial Instruments for additional details.

There were no tax impacts on Other comprehensive income (loss) attributable to Noncontrolling interests.

XML

Fair Value Measurements and Financial Instruments (Details 3) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Fair Value Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	$ 2,369	$ 2,423
Activity related to fair value hedges [Abstract]
Gain (loss) on derivative	(8)	5
Gain (loss) on hedged items	8	(5)
Fair Value Hedging [Member] | Foreign Currency Contracts [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	681	1,085
Activity related to fair value hedges [Abstract]
Gain (loss) on derivative	2	12
Gain (loss) on hedged items	(2)	(12)
Fair Value Hedging [Member] | Interest Rate Swap Contracts [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	1,688	1,338
Activity related to fair value hedges [Abstract]
Gain (loss) on derivative	(10)	(7)
Gain (loss) on hedged items	10	7
Cash Flow Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	416	498
Activity related to cash flow hedges [Abstract]
Gain (loss) recognized in OCI	2	7
Gain (loss) reclassified into Cost of sales	3	4
Cash Flow Hedging [Member] | Foreign Currency Contracts [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	401	446
Activity related to cash flow hedges [Abstract]
Gain (loss) recognized in OCI	0	8
Gain (loss) reclassified into Cost of sales	2	3
Cash Flow Hedging [Member] | Commodity Contracts [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	15	52
Activity related to cash flow hedges [Abstract]
Gain (loss) recognized in OCI	2	(1)
Gain (loss) reclassified into Cost of sales	1	1
Net Investment Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	936	911
Activity related to net investment hedges [Abstract]
Gain (loss) on instruments	1	27
Gain (loss) on hedged items	0	(26)
Net Investment Hedging [Member] | Foreign Currency Contracts [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	680	536
Activity related to net investment hedges [Abstract]
Gain (loss) on instruments	0	14
Gain (loss) on hedged items	1	(13)
Net Investment Hedging [Member] | Foreign Currency Denominated Debt [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	256	375
Activity related to net investment hedges [Abstract]
Gain (loss) on instruments	1	13
Gain (loss) on hedged items	(1)	(13)
Not Designated as Hedging Instrument [Member] | Cross-Currency Swap [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative, Notional Amount	96	96
Activity related to derivatives not designated as hedging instruments [Abstract]
Gain (loss) on instrument	(1)	6
Gain (loss) on hedged item	$ 1	$ (6)

XML

Retirement Plans and Other Retiree Benefits (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Contributions by Employer	$ 0	$ 0
United States Pension Benefits [Member]
Components of net periodic benefit cost
Service Cost	0	7
Interest cost	25	23
Expected return on plan assets	(27)	(29)
Amortization of transition and prior service costs (credits)	0	2
Amortization of actuarial loss	8	16
Net periodic benefit cost	6	19
International Pension Benefits [Member]
Components of net periodic benefit cost
Service Cost	5	6
Interest cost	9	7
Expected return on plan assets	(7)	(6)
Amortization of transition and prior service costs (credits)	1	0
Amortization of actuarial loss	1	3
Net periodic benefit cost	9	10
Other Retiree Benefits [Member]
Components of net periodic benefit cost
Service Cost	3	4
Interest cost	10	10
Expected return on plan assets	0	(1)
Amortization of transition and prior service costs (credits)	0	0
Amortization of actuarial loss	4	5
Net periodic benefit cost	$ 17	$ 18

XML

Recent Accounting Pronouncements

3 Months Ended

Mar. 31, 2014

New Accounting Pronouncements and Changes in Accounting Principles [Abstract]

New Accounting Pronouncements and Changes in Accounting Principles [Text Block]

Recent Accounting Pronouncements

On April 10, 2014, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2014-08 “Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity.” ASU No. 2014-08 changes the criteria for reporting discontinued operations and modifies related disclosure requirements. The new guidance is effective on a prospective basis for fiscal years beginning after December 15, 2014, and interim periods within annual periods beginning on or after December 15, 2015. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements.

XML

Fair Value Measurements and Financial Instruments (Details 4) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2014 USD ($)	Mar. 31, 2013 USD ($)	Mar. 31, 2014 VEF	Dec. 31, 2012 VEF	Mar. 31, 2014 Bonds Issued By Venezuelan Government [Member] USD ($)	Dec. 31, 2013 Bonds Issued By Venezuelan Government [Member] USD ($)	Mar. 31, 2013 Bonds Issued By Venezuelan Government [Member] USD ($)	Dec. 31, 2012 Bonds Issued By Venezuelan Government [Member] USD ($)	Mar. 31, 2014 Other Current Assets [Member] USD ($)	Dec. 31, 2013 Other Current Assets [Member] USD ($)	Mar. 31, 2014 Fair Value, Inputs, Level 2 [Member] Bonds Issued By Venezuelan Government [Member] USD ($)	Mar. 31, 2014 Fair Value, Inputs, Level 2 [Member] Other Current Assets [Member] Bonds Issued By Venezuelan Government [Member] USD ($)	Mar. 31, 2014 Fair Value, Inputs, Level 2 [Member] Estimate of Fair Value Measurement [Member] Other Assets [Member] Bonds Issued By Venezuelan Government [Member] USD ($)	Dec. 31, 2013 Fair Value, Inputs, Level 2 [Member] Estimate of Fair Value Measurement [Member] Other Assets [Member] Bonds Issued By Venezuelan Government [Member] USD ($)	Mar. 31, 2014 Fair Value, Inputs, Level 1 [Member] Other Current Assets [Member] USD ($)
Schedule of Available-for-sale Securities [Line Items]
Loss related to the remeasurement of fixed interest rate and devaluations-protected bonds in Venezuela	$ 276
Loss related to the remeasurement of fixed interest rate bonds in Venezuela		133
Marketable Securities									243	173		48			195
Available-for-sale Securities					441	685	598	642					393	685
Fair Value of U.S. dollar-linked, devaluation-protected bonds											137
Fair Value of fixed interest rate bonds											$ 304
Official currency exchange rate in Venezuela for non-essential goods prior to devaluation beginning February 9, 2013				4.30
Official currency exchange rate in Venezuela for non-essential goods beginning February 9, 2013			6.30

XML

Acquisitions and Divestitures (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Sep. 30, 2012	Sep. 30, 2011
Sale of Land in Mexico [Abstract]
First Installment received from the sale of land in Mexico				$ 24
Second Installment received from the sale of land in Mexico			36
Pretax costs related to sale of land	1	5
Aftertax costs related to sale of land	$ 1	$ 3

XML

Fair Value Measurements and Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2014

Notes to Financial Statements [Abstract]

Schedule of derivative instruments

The following summarizes the fair value of the Company’s derivative instruments and other financial instruments at March 31, 2014 and December 31, 2013:

	Assets					Liabilities
	Account	Fair Value				Account	Fair Value
Designated derivative instruments		3/31/14		12/31/13			3/31/14		12/31/13
Interest rate swap contracts	Other current assets	$	—	$	1	Other accruals	$	—	$	—
Interest rate swap contracts	Other assets	17		20		Other liabilities	7		1
Foreign currency contracts	Other current assets	7		14		Other accruals	7		8
Foreign currency contracts	Other assets	—		—		Other liabilities	7		10
Commodity contracts	Other current assets	1		—		Other accruals	—		—
Total designated		$	25	$	35		$	21	$	19
Derivatives not designated
Foreign currency contracts	Other current assets	$	—	$	—	Other accruals	$	4	$	3
Total not designated		$	—	$	—		$	4	$	3
Total derivative instruments		$	25	$	35		$	25	$	22
Other financial instruments
Marketable securities	Other current assets	$	243	$	173
Available-for-sale securities	Other assets	393		685
Total other financial instruments		$	636	$	858

Activity related to fair value hedges

Activity related to fair value hedges recorded during the three-month periods ended March 31, 2014 and 2013 was as follows:

	2014									2013
	Foreign Currency Contracts			Interest Rate Swaps			Total			Foreign Currency Contracts			Interest Rate Swaps			Total
Notional Value at March 31,	$	681		$	1,688		$	2,369		$	1,085		$	1,338		$	2,423
Three months ended March 31:
Gain (loss) on derivative	2			(10		)	(8		)	12			(7		)	5
Gain (loss) on hedged items	(2		)	10			8			(12		)	7			(5		)

Activity related to cash flow hedges

Activity related to cash flow hedges recorded during the three-month periods ended March 31, 2014 and 2013 was as follows:

	2014						2013
	Foreign Currency Contracts		Commodity Contracts		Total		Foreign Currency Contracts		Commodity Contracts			Total
Notional Value at March 31,	$	401	$	15	$	416	$	446	$	52		$	498
Three months ended March 31:
Gain (loss) recognized in OCI	—		2		2		8		(1		)	7
Gain (loss) reclassified into Cost of sales	2		1		3		3		1			4

Activity related to net investment hedges

Activity related to net investment hedges recorded during the three-month periods ended March 31, 2014 and 2013 was as follows:

	2014							2013
	Foreign Currency Contracts		Foreign Currency Debt			Total		Foreign Currency Contracts			Foreign Currency Debt			Total
Notional Value at March 31,	$	680	$	256		$	936	$	536		$	375		$	911
Three months ended March 31:
Gain (loss) on instruments	—		1			1		14			13			27
Gain (loss) on hedged items	1		(1		)	—		(13		)	(13		)	(26		)

Activity related to derivatives not designated as hedging instruments

Activity related to these contracts during the three-month periods ended March 31, 2014 and 2013 was as follows:

	2014			2013
	Cross-currency Swap			Cross-currency Swap
Notional Value at March 31,	$	96		$	96
Three months ended March 31:
Gain (loss) on instrument	(1		)	6
Gain (loss) on hedged item	1			(6		)

Reconciliation of the Venezuelan investments at fair value

The following table presents a reconciliation of the Venezuelan bonds at fair value for the three months endedMarch 31, 2014 and 2013:

	2014			2013
Beginning balance as of January 1,	$	685		$	642
Unrealized gain (loss) on investment	(298		)	(141		)
Purchases and sales during the period	54			97
Ending balance as of March 31,	$	441		$	598

XML

Fair Value Measurements and Financial Instruments (Details 5) (Bonds Issued By Venezuelan Government [Member], USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Bonds Issued By Venezuelan Government [Member]
Venezuelan Investments [Roll Forward]
Beginning balance	$ 685	$ 642
Unrealized gain (loss) on investment	(298)	(141)
Purchases and sales during the period	54	97
Ending balance	$ 441	$ 598

XML

Restructuring and Related Implementation Charges (Details) (Two Thousand Twelve Restructuring Program [Member], USD $) In Millions, unless otherwise specified	3 Months Ended		18 Months Ended	3 Months Ended	18 Months Ended		3 Months Ended	18 Months Ended	3 Months Ended	18 Months Ended		3 Months Ended		3 Months Ended			18 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2014 One-time Termination Benefits [Member]	Mar. 31, 2014 One-time Termination Benefits [Member]	Mar. 31, 2014 Incremental Depreciation And Asset Impairment [Member]	Mar. 31, 2014 Incremental Depreciation [Member]	Mar. 31, 2014 Incremental Depreciation [Member]	Mar. 31, 2014 Asset Impairment [Member]	Mar. 31, 2014 Asset Impairment [Member]	Mar. 31, 2014 Charges Resulting Directly From Exit Activities [Member]	Mar. 31, 2014 Contract Termination [Member]	Mar. 31, 2014 Implementation Of New Strategies [Member]	Mar. 31, 2014 Third party Incremental Cost [Member]	Mar. 31, 2014 Land and Building [Member]	Mar. 31, 2014 Other Restructuring [Member]	Mar. 31, 2014 Other Restructuring [Member]	Dec. 31, 2012 Expected Completion Date 2016 employees	Mar. 31, 2014 Expected Completion Date 2016 Minimum [Member]	Mar. 31, 2014 Expected Completion Date 2016 Maximum [Member]	Mar. 31, 2014 Expected Completion Date December 2014 [Member] Minimum [Member]	Mar. 31, 2014 Expected Completion Date December 2014 [Member] Maximum [Member]
Restructuring Cost and Reserve [Line Items]
Duration Of Restructuring Program	4 years
Restructuring Program Expected Cost Before Tax																			$ 1,100	$ 1,250	$ 275	$ 325
Restructuring Program Expected Cost After Tax																			775	875	200	230
Expected Percent of Total Pretax Charges by Category				50.00%	50.00%	15.00%					20.00%		15.00%
Expected Percent of Total Charges Resulting In Cash Expenditure	75.00%		75.00%
Percentage Reduction Of Global Employee Workforce																		6.00%
Number of Employees as of the Start of the 2012 Restructuring Program																		38,000
Pretax charges related to the 2012 Restructuring Program	102	66		20			6		0			21		16	39	76
Pretax charges related to the 2012 Restructuring Program to date			562		242			32		1							287
Aftertax charges related to the 2012 Restructuring Program to date			421
Charges Against Assets	$ (7)			$ (1)			$ (6)		$ 0							$ 0

XML

Restructuring and Related Implementation Charges (Details 1) (Two Thousand Twelve Restructuring Program [Member], USD $) In Millions, unless otherwise specified	3 Months Ended		18 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the 2012 Restructuring Program	$ 102	$ 66
Aftertax charges related to the 2012 Restructuring Program	73	52
Cost of Sales [Member]
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the 2012 Restructuring Program	10	8
Selling, General and Administrative Expenses [Member]
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the 2012 Restructuring Program	17	8
Other (Income) Expense, Net [Member]
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the 2012 Restructuring Program	$ 75	$ 50
Pet Nutrition [Member]
Restructuring Cost and Reserve [Line Items]
Expected Percent of Total Restructuring Charges Related to Segment	10.00%		10.00%
Percent of Restructuring Charges Related to Segment for Period	8.00%	3.00%
Percent of Restructuring Charges Related to Segment Program to Date			7.00%
Corporate, Non-Segment [Member]
Restructuring Cost and Reserve [Line Items]
Expected Percent of Total Restructuring Charges Related to Segment	40.00%		40.00%
Percent of Restructuring Charges Related to Segment for Period	56.00%	45.00%
Percent of Restructuring Charges Related to Segment Program to Date			44.00%
North America [Member]
Restructuring Cost and Reserve [Line Items]
Expected Percent of Total Restructuring Charges Related to Segment	15.00%		15.00%
Percent of Restructuring Charges Related to Segment for Period	9.00%
Percent of Restructuring Charges Related to Segment Program to Date			10.00%
Latin America [Member]
Restructuring Cost and Reserve [Line Items]
Expected Percent of Total Restructuring Charges Related to Segment	5.00%		5.00%
Percent of Restructuring Charges Related to Segment for Period	4.00%	15.00%
Percent of Restructuring Charges Related to Segment Program to Date			3.00%
Europe/South Pacific [Member]
Restructuring Cost and Reserve [Line Items]
Expected Percent of Total Restructuring Charges Related to Segment	20.00%		20.00%
Percent of Restructuring Charges Related to Segment for Period	21.00%	31.00%
Percent of Restructuring Charges Related to Segment Program to Date			31.00%
Asia [Member]
Restructuring Cost and Reserve [Line Items]
Expected Percent of Total Restructuring Charges Related to Segment	5.00%		5.00%
Africa/Eurasia [Member]
Restructuring Cost and Reserve [Line Items]
Expected Percent of Total Restructuring Charges Related to Segment	5.00%		5.00%
Percent of Restructuring Charges Related to Segment for Period	2.00%	6.00%
Percent of Restructuring Charges Related to Segment Program to Date			5.00%

XML

Use of Estimates

3 Months Ended

Mar. 31, 2014

Notes to Financial Statements [Abstract]

Use of Estimates

Use of Estimates

Provisions for certain expenses, including income taxes, media advertising and consumer promotion, are based on full year assumptions and are included in the accompanying Condensed Consolidated Financial Statements in proportion with estimated annual tax rates, the passage of time or estimated annual sales.

XML

Restructuring and Related Implementation Charges (Details 2) (Two Thousand Twelve Restructuring Program [Member], USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Restructuring Reserve [Roll Forward]
Balance	$ 158
Charges	102	66
Cash payments	(54)
Charges Against Assets	(7)
Foreign exchange	(2)
Balance	197
One-time Termination Benefits [Member]
Restructuring Reserve [Roll Forward]
Balance	116
Charges	20
Cash payments	(31)
Charges Against Assets	(1)
Foreign exchange	(1)
Balance	103
Incremental Depreciation [Member]
Restructuring Reserve [Roll Forward]
Balance	0
Charges	6
Cash payments	0
Charges Against Assets	(6)
Foreign exchange	0
Balance	0
Asset Impairment [Member]
Restructuring Reserve [Roll Forward]
Balance	0
Charges	0
Cash payments	0
Charges Against Assets	0
Foreign exchange	0
Balance	0
Other Restructuring [Member]
Restructuring Reserve [Roll Forward]
Balance	42
Charges	76
Cash payments	(23)
Charges Against Assets	0
Foreign exchange	(1)
Balance	$ 94

XML

Fair Value Measurements and Financial Instruments (Details 1) (USD $) In Millions, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Derivative and Financial Instruments, Fair Value [Line Items]
Total assets derivatives	$ 25	$ 35
Total liabilities derivatives	25	22
Financial Instruments, Owned, at Fair Value [Abstract]
Total other financial instruments	636	858
Designated derivative instruments
Derivative Assets	25	35
Derivative Liabilities	21	19
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value	0	0
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	4	3
Other Current Assets [Member]
Derivative and Financial Instruments, Fair Value [Line Items]
Marketable Securities	243	173
Interest Rate Swap Contracts [Member] | Other Current Assets [Member]
Designated derivative instruments
Derivative Assets	0	1
Interest Rate Swap Contracts [Member] | Other Assets [Member]
Designated derivative instruments
Derivative Assets	17	20
Interest Rate Swap Contracts [Member] | Other Accruals [Member]
Designated derivative instruments
Derivative Liabilities	0	0
Interest Rate Swap Contracts [Member] | Other Liabilities [Member]
Designated derivative instruments
Derivative Liabilities	7	1
Foreign Currency Contracts [Member] | Other Current Assets [Member]
Designated derivative instruments
Derivative Assets	7	14
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value	0	0
Foreign Currency Contracts [Member] | Other Assets [Member]
Designated derivative instruments
Derivative Assets	0	0
Foreign Currency Contracts [Member] | Other Accruals [Member]
Designated derivative instruments
Derivative Liabilities	7	8
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	4	3
Foreign Currency Contracts [Member] | Other Liabilities [Member]
Designated derivative instruments
Derivative Liabilities	7	10
Commodity Contracts [Member] | Other Current Assets [Member]
Designated derivative instruments
Derivative Assets	1	0
Commodity Contracts [Member] | Other Accruals [Member]
Designated derivative instruments
Derivative Liabilities	0	0
Bonds Issued By Venezuelan Government [Member] | Fair Value, Inputs, Level 2 [Member] | Other Current Assets [Member]
Derivative and Financial Instruments, Fair Value [Line Items]
Marketable Securities	48
Bonds Issued By Venezuelan Government [Member] | Fair Value, Inputs, Level 2 [Member] | Estimate of Fair Value Measurement [Member] | Other Assets [Member]
Financial Instruments, Owned, at Fair Value [Abstract]
Available-for-sale Securities, Fair Value Disclosure	$ 393	$ 685

XML

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2014		Mar. 31, 2013
Net sales	$ 4,325		$ 4,315
Cost of sales	1,801		1,800
Gross profit	2,524		2,515
Selling, general and administrative expenses	1,544		1,536
Other (income) expense, net	346		237
Operating profit	634		742
Interest (income) expense, net	7		(3)
Income before income taxes	627		745
Provision for income taxes	195		239
Net income including noncontrolling interests	432		506
Less: Net income attributable to noncontrolling interests	44		46
Net income attributable to Colgate-Palmolive Company	$ 388		$ 460
Earnings per common share, basic (in dollars per share)	$ 0.42		$ 0.49
Earnings per common share, diluted (in dollars per share)	$ 0.42		$ 0.48
Dividends declared per common share (in dollars per share)	$ 0.70	[1]	$ 0.65	[1]

[1] Two dividends were declared in each period.

XML

Venezuela (Details) In Millions, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2014 USD ($)	Mar. 31, 2013 USD ($)	Mar. 31, 2014 VEF	Dec. 31, 2012 VEF
Notes to Financial Statements [Abstract]
Official currency exchange rate in Venezuela for non-essential goods prior to devaluation beginning February 9, 2013				4.30
Official currency exchange rate in Venezuela for non-essential goods beginning February 9, 2013			6.30
SICAD Exchange Rate in Venezuela at March 31, 2014			10.70
Pretax Venezuela Remeasurement Charge	$ 266	$ 172
Aftertax Venezuela Remeasurement Charge	174	111
Impact of aftertax Venezuela devaluation charge per common share diluted	$ 0.19
Percentage of consolidated Net sales represented by CP Venezuela (in hundredths)	3.00%
CP Venezuela bolivar fuerte denominated monetary net asset position	489
Venezuela Subsidiary Bolivar Fuerte Denominated Non Monetary Asset Position	337
Venezuela Subsidiary Bolivar Fuerte Denominated Non Monetary Fixed Asset Position	$ 226

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Operating Activities
Net income including noncontrolling interests	$ 432	$ 506
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:
Depreciation and amortization	108	110
Restructuring and termination benefits, net of cash	45	30
Pretax Venezuela Remeasurement Charge	266	172
Stock-based compensation expense	34	32
Deferred income taxes	(21)	(17)
Cash effects of changes in:
Receivables	(77)	(175)
Inventories	(67)	(15)
Accounts payable and other accruals	100	112
Other non-current assets and liabilities	0	22
Net cash provided by operations	820	777
Investing Activities
Capital expenditures	(168)	(94)
Purchases of marketable securities and investments	(151)	(199)
Proceeds from sale of marketable securities and investments	74	54
Payments for acquisitions, net of cash acquired	(25)	0
Other	21	7
Net cash used in investing activities	(249)	(232)
Financing Activities
Principal payments on debt	(1,938)	(1,436)
Proceeds from issuance of debt	2,960	1,553
Dividends paid	(316)	(290)
Purchases of treasury shares	(453)	(385)
Proceeds from exercise of stock options and excess tax benefits	50	96
Net cash used in financing activities	303	(462)
Effect of exchange rate changes on Cash and cash equivalents	(41)	(35)
Net increase (decrease) in Cash and cash equivalents	833	48
Cash and cash equivalents at beginning of the period	962	884
Cash and cash equivalents at end of the period	1,795	932
Supplemental Cash Flow Information
Income taxes paid	$ 171	$ 182

XML

Earnings Per Share (Details) (USD $) In Millions, except Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Earnings Per Share Reconciliation [Abstract]
Net income attributable to Colgate-Palmolive Company, Basic	$ 388	$ 460
Net income attributable to Colgate-Palmolive Company, Diluted	$ 388	$ 460
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Basic EPS (in shares)	919,500,000	936,600,000
Stock options and restricted stock (in shares)	9,100,000	8,400,000
Diluted EPS (in shares)	928,600,000	945,000,000
Earnings Per Share, Basic and Diluted [Abstract]
Earnings Per Share, Basic	$ 0.42	$ 0.49
Earnings Per Share, Diluted	$ 0.42	$ 0.48
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	3,374,995	3,750,570

XML

Inventories (Tables)

3 Months Ended

Mar. 31, 2014

Inventory, Net [Abstract]

Inventories By Major Class

Inventories by major class are as follows:

	March 31, 2014		December 31, 2013
Raw materials and supplies	$	338	$	340
Work-in-process	63		60
Finished goods	1,077		1,025
Total Inventories	$	1,478	$	1,425

XML

Other Comprehensive Income (Details) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2014 USD ($)		Mar. 31, 2013 USD ($)		Mar. 31, 2014 VEF	Dec. 31, 2012 VEF
Other Comprehensive Income (Loss) [Abstract]
Cumulative translation adjustments, before-tax	$ (39)		$ (45)
Cumulative translation adjustment, net-of-tax	(43)		(55)
Pension and other benefits:
Net actuarial gains (losses) and prior service costs arising during the period, before-tax	3		3
Net actuarial gains (losses) and prior service costs arising during the period, net-of-tax	2		2
Amortization of net actuarial loss, transition & prior service costs, before-tax	14	[1]	26	[1]
Amortization of net actuarial loss, transition & prior service costs, net-of-tax	11	[1]	18	[1]
Retirement Plan and other retiree benefit adjustments, before-tax	17		29
Retirement Plan and other retiree benefit adjustments, net-of-tax	13		20
Available-for-sale securities:
Unrealized gains (losses) on available-for-sale securities, before-tax	(298)	[2]	(141)	[2]
Unrealized gains (losses) on available-for-sale securities, net-of-tax	(194)	[2]	(90)	[2]
Reclassification of (gains) losses into net earnings on available-for-sale securities, before-tax	211	[3]	133	[3]
Reclassification of (gains) losses into net earnings on available-for-sale securities, net-of-tax	138	[3]	86	[3]
Gains (losses) on available-for-sale securities, before-tax	(87)		(8)
Gains (losses) on available-for-sale securities, net-of-tax	(56)		(4)
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges, before-tax	2		7
Unrealized gains (losses) on cash flow hedges, net-of-tax	1		5
Reclassification of (gains) losses into net earnings on cash flow hedges, before-tax	(3)	[4]	(4)	[4]
Reclassification of (gains) losses into net earnings on cash flow hedges, net-of-tax	(1)	[4]	(3)	[4]
Gains (losses) on cash flow hedges, before-tax	(1)		3
Gains (losses) on cash flow hedges, net-of-tax	0		2
Total other comprehensive income (loss), before-tax	(110)		(21)
Total other comprehensive income (loss), net-of-tax	(86)		(37)
Remeasurement Due To Change in Foreign Exchange Rates [Abstract]
Loss related to the remeasurement of fixed interest rate and devaluations-protected bonds in Venezuela	276
Loss related to the remeasurement of fixed interest rate bonds in Venezuela			$ 133
Official currency exchange rate in Venezuela for non-essential goods prior to devaluation beginning February 9, 2013						4.30
Official currency exchange rate in Venezuela for non-essential goods beginning February 9, 2013					6.30

[1] These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 10, Retirement Plans and Other Retiree Benefits for additional details.

[2] For the three months ended March 31, 2014, these amounts included pretax losses of $276 related to the remeasurement of the bolivar denominated fixed interest rate bonds and the devaluation-protected bonds in Venezuela as a result of the effective devaluation in the first quarter of 2014. For the three months ended March 31, 2013, these amounts included pretax losses of $133 only related to the remeasurement of the bolivar denominated fixed interest rate bonds in Venezuela as a result of the devaluation in the first quarter of 2013. No remeasurement charge was required on the devaluation-protected bonds in the first quarter of 2013 since the official exchange rate changed from 4.30 to 6.30 bolivares per dollar and the devaluation-protected bonds revalued to the official exchange rate. See Note 13, Fair Value Measurements and Financial Instruments for additional details.

[3] Represents reclassification of (gains) losses on the Venezuela bonds into Other (income) expense, net due to an impairment in the fair value of the bonds as a result of the effective devaluation in the first quarter of 2014 and the devaluation in the first quarter of 2013. See Note 13, Fair Value Measurements and Financial Instruments for additional details.

[4] These (gains) losses are reclassified into Cost of sales. See Note 13, Fair Value Measurements and Financial Instruments for additional details.

XML

Earnings Per Share (Tables)

3 Months Ended

Mar. 31, 2014

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

	Three Months Ended
	March 31, 2014					March 31, 2013
	Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share
Basic EPS	$	388	919.5	$	0.42	$	460	936.6	$	0.49
Stock options and restricted stock			9.1					8.4
Diluted EPS	$	388	928.6	$	0.42	$	460	945.0	$	0.48

For the three months endedMarch 31, 2014 and 2013, the average number of stock options and restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 3,374,995 and 3,750,570, respectively.

XML

Basis of Presentation

3 Months Ended

Mar. 31, 2014

Notes to Financial Statements [Abstract]

Basis of Presentation

Basis of Presentation

The Condensed Consolidated Financial Statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair statement of the results for interim periods. Results of operations for interim periods may not be representative of results to be expected for a full year. Certain prior year amounts have been reclassified to conform to the current year presentation.

For a complete set of financial statement notes, including the significant accounting policies of Colgate-Palmolive Company (together with its subsidiaries, the “Company” or “Colgate”), refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2013, filed with the Securities and Exchange Commission.

XML

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Net income including noncontrolling interests	$ 432	$ 506
Other comprehensive income (loss), net of tax:
Cumulative translation adjustments	(44)	(55)
Retirement Plan and other retiree benefit adjustments	13	20
Gains (losses) on available-for-sale securities	(56)	(4)
Gains (losses) on cash flow hedges	0	2
Total Other comprehensive (loss) income, net of tax	(87)	(37)
Total Comprehensive income including noncontrolling interests	345	469
Less: Net income attributable to noncontrolling interests	44	46
Less: Cumulative translation adjustments attributable to noncontrolling interests	(1)	0
Total Comprehensive Income attributable to noncontrolling interests	43	46
Total Comprehensive income attributable to Colgate-Palmolive Company	$ 302	$ 423

XML

Contingencies

3 Months Ended

Mar. 31, 2014

Loss Contingency [Abstract]

Contingencies

Contingencies

As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, environmental and tax matters and consumer class actions. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites.

As a matter of course, the Company is regularly audited by the IRS and other tax authorities around the world in countries where it conducts business. In this regard, all U.S. federal income tax returns through December 31, 2009 have been audited by, and settled with, the IRS. With a few exceptions, the Company is no longer subject to U.S., state and local income tax examinations for the years prior to 2009. In addition, the Company has subsidiaries in various foreign jurisdictions that have statutes of limitations for tax audits generally ranging from three to six years.

The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances.

The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $250 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company from the matters in question. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above.

Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more of these matters could be material to the Company’s results of operations or cash flows for any particular quarter or year.

Brazilian Matters

There are certain tax and civil proceedings outstanding, as described below, related to the Company’s 1995 acquisition of the Kolynos oral care business from Wyeth (the “Seller”).

The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, at the current exchange rate, are approximately $120. The Company has been disputing the disallowances by appealing the assessments within the internal revenue authority’s appellate process with the following results to date:

▪ In June 2005, the First Board of Taxpayers ruled in the Company’s favor and allowed all of the previously claimed deductions for 1996 through 1998. In March 2007, the First Board of Taxpayers ruled in the Company’s favor and allowed all of the previously claimed deductions for 1999 through 2001. The tax authorities appealed these decisions to the next administrative level.

▪ In August 2009, the First Taxpayers’ Council (the next and final administrative level of appeal) overruled the decisions of the First Board of Taxpayers, upholding the majority of the assessments, disallowing a portion of the assessments and remanding a portion of the assessments for further consideration by the First Board of Taxpayers.

The Company has filed a motion for clarification with a special appeals chamber of the Taxpayers’ Council, and further appeals are available within the Brazilian federal courts. The Company intends to challenge these assessments vigorously. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel and other advisors, that the disallowances are without merit and that the Company should ultimately prevail on appeal, if necessary, in the Brazilian federal courts.

In 2002, the Brazilian Federal Public Attorney filed a civil action against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company, as represented by its Brazilian subsidiary, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The action seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the Company should ultimately prevail in this action. The Company intends to challenge this action vigorously.

In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest and penalties of approximately $75, at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. The Company is disputing the assessment within the internal revenue authority’s administrative appeals process. In October 2007, the Second Board of Taxpayers, which has jurisdiction over these matters, ruled in favor of the internal revenue authority. In January 2008, the Company appealed this decision, and in January 2012, a special appeals chamber of the Taxpayers’ Council denied the Company’s appeal. The Company has filed a motion for clarification with a special appeals chamber of the Taxpayers’ Council and further appeals are available within the Brazilian federal courts. Although there can be no assurances, management believes, based on the advice of its Brazilian legal counsel, that the tax assessment is without merit and that the Company should prevail on appeal, if not at the administrative level, in the Brazilian federal courts. The Company intends to challenge this assessment vigorously.

Competition Matters

European Competition Matters

Certain of the Company’s subsidiaries in Europe are subject to investigations, and in some cases, fines by governmental authorities in a number of European countries related to potential competition law violations. The Company understands that substantially all of these matters also involve other consumer goods companies and/or retail customers. The status of the various pending matters is discussed below.

Fines have been imposed on the Company in the following matters, although, as noted below, the Company has appealed each of these fines:

▪ In December 2009, the Swiss competition law authority imposed a fine of $6 on the Company’s GABA subsidiary for alleged violations of restrictions on parallel imports into Switzerland, which the Company appealed. In January 2014, this appeal was denied. The Company is appealing before the Swiss Supreme Court.

▪ In January 2010, the Company’s Spanish subsidiary was fined $3 by the Spanish competition law authority on the basis that it had entered an agreement with other shower gel manufacturers regarding product downsizing, which the Company contested. The fine was annulled by the Court of Appeal in July 2013. The Spanish competition law authority is appealing this judgment before the Spanish Supreme Court.

▪ In December 2010, the Italian competition law authority found that 16 consumer goods companies, including the Company’s Italian subsidiary, exchanged competitively sensitive information in the cosmetics sector, for which the Company’s Italian subsidiary was fined $3. The Company is appealing the fine in the Italian courts.

▪ In March 2012, the French competition law authority found that three pet food producers, including the Company’s Hill’s French subsidiary, had violated the competition law, for which it imposed a fine of $7 on the Company’s Hill’s French subsidiary for alleged restrictions on exports from France, which the Company contested. In October 2013, the Company’s appeal was denied. The Company is appealing before the French Supreme Court.

Currently, formal claims of violations, or statements of objections, are pending against the Company as follows:

▪ In October 2012, the Belgian competition law authority alleged that 11 branded goods companies, including the Company’s Belgian subsidiary, assisted retailers to coordinate their retail prices on the Belgian market. The Company is in the process of responding to this statement of objections.

▪ In June 2013, the French competition law authority issued a statement of objections alleging that the Company’s French subsidiary and a number of its competitors exchanged sensitive information related to the French home care and personal care sectors. The Company has responded to this statement of objections.

An investigation is ongoing in Greece, but no formal claim of violations has been filed.

Since December 31, 2013, the following matter has been resolved:

▪ In January 2014, the French Court of Appeal confirmed the French competition law authority’s December 2011 fine of the Company’s French subsidiary, in the amount of $46, in connection with a divested heavy duty detergent business.

Australian Competition Matter

In December 2013, the Australian competition law authority instituted civil proceedings in the Sydney registry of the Federal Court of Australia alleging that three consumer goods companies, including the Company’s Australian subsidiary, a retailer and a former employee of the Company’s Australian subsidiary violated the Australian competition law by coordinating the launching and pricing of ultra concentrated laundry detergents. The Company intends to challenge these proceedings vigorously. Since the amount of any potential losses from these proceedings currently cannot be estimated, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to these proceedings.

The Company’s policy is to comply with antitrust and competition laws and, if a violation of any such laws is found, to take appropriate remedial action and to cooperate fully with any related governmental inquiry. Competition and antitrust law investigations often continue for several years and can result in substantial fines for violations that are found. While the Company cannot predict the final financial impact of these competition law issues as these matters may change, the Company evaluates developments in these matters quarterly and accrues liabilities as and when appropriate.

Talcum Powder Matters

The Company is a defendant in a number of civil actions alleging that certain talc products it sold prior to 1996 were contaminated with asbestos. Since 2008, the Company has and will continue to challenge these cases vigorously, and although there can be no assurances, it believes, based on the advice of its legal counsel, that they are without merit and the Company should ultimately prevail. Currently, there are 12 single plaintiff cases pending against the Company in state courts in Delaware, Maryland, New Jersey and New York and one case pending in federal court in North Carolina. Fourteen similar cases previously filed against the Company have been dismissed and final judgment entered in favor of the Company. To date, there have been no findings of liability against the Company in any of these cases. Since the amount of any potential losses from these cases at trial currently cannot be estimated, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to these cases.

In 2014, two of these cases are tentatively scheduled to go to trial, although the Company may succeed in dismissing some or all of them prior to trial. As stated above, the Company believes that it will ultimately prevail as it has in all similar cases.

ERISA Matters

In October 2007, a putative class action claiming that certain aspects of the cash balance portion of the Colgate-Palmolive Company Employees’ Retirement Income Plan (the “Plan”) do not comply with the Employee Retirement Income Security Act was filed against the Plan and the Company in the United States District Court for the Southern District of New York. Specifically, Proesel, et al. v. Colgate-Palmolive Company Employees’ Retirement Income Plan, et al. alleges improper calculation of lump sum distributions, age discrimination and failure to satisfy minimum accrual requirements, thereby resulting in the underpayment of benefits to Plan participants.

Two other putative class actions filed earlier in 2007, Abelman, et al. v. Colgate-Palmolive Company Employees’ Retirement Income Plan, et al., in the United States District Court for the Southern District of Ohio, and Caufield v. Colgate-Palmolive Company Employees’ Retirement Income Plan, in the United States District Court for the Southern District of Indiana, both alleging improper calculation of lump sum distributions and, in the case of Abelman, claims for failure to satisfy minimum accrual requirements, were transferred to the Southern District of New York and consolidated with Proesel into one action, In re Colgate-Palmolive ERISA Litigation. The complaint in the consolidated action alleges improper calculation of lump sum distributions and failure to satisfy minimum accrual requirements, but does not include a claim for age discrimination. The relief sought includes recalculation of benefits in unspecified amounts, pre- and post-judgment interest, injunctive relief and attorneys’ fees. In October 2013, the parties executed a settlement agreement under which the Plan would pay approximately $40 after application of certain offsets to resolve the litigation. The settlement agreement is subject to court approval. On December 16, 2013, a motion for preliminary approval of a class action settlement, class certification and appointment of class counsel was approved. A final approval hearing was held on April 4, 2014 and the court is considering final approval. The Company and the Plan intend to contest this action vigorously should the settlement not be approved and finalized.

XML

Document and Entity Information	3 Months Ended
	Mar. 31, 2014
Entity Information [Line Items]
Entity Registrant Name	COLGATE PALMOLIVE CO
Entity Central Index Key	0000021665
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding	915,386,382
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	Q1
Document Type	10-Q
Amendment Flag	false
Trading Symbol	CL
Document Period End Date	Mar. 31, 2014

XML

Segment Information

3 Months Ended

Mar. 31, 2014

Notes to Financial Statements [Abstract]

Segment Information

Segment Information

The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition.  The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.

The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of corporate-driven decisions related to interest expense and income taxes. Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation costs and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of operating segment performance used by the Company to measure the underlying performance of the operating segments.

Net sales and Operating profit by segment were as follows:

	Three Months Ended
	March 31,
	2014			2013
Net sales
Oral, Personal and Home Care
North America	$	785		$	764
Latin America	1,152			1,214
Europe/South Pacific	865			848
Asia	672			655
Africa/Eurasia	298			300
Total Oral, Personal and Home Care	3,772			3,781
Pet Nutrition	553			534
Total Net sales	$	4,325		$	4,315
Operating profit
Oral, Personal and Home Care
North America	$	216		$	215
Latin America	290			312
Europe/South Pacific	217			200
Asia	193			186
Africa/Eurasia	59			62
Total Oral, Personal and Home Care	975			975
Pet Nutrition	144			136
Corporate	(485		)	(369		)
Total Operating profit	$	634		$	742

Approximately 80% of the Company’s Net sales are generated from markets outside the U.S., with over 50% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe).

For the three months ended March 31, 2014, Corporate Operating profit (loss) includes charges of $102 associated with the 2012 Restructuring Program, a charge of $266 related to the Venezuela remeasurement and costs of $1 related to the sale of land in Mexico. For the three months ended March 31, 2013, Corporate Operating profit (loss) included charges of $66 associated with the 2012 Restructuring Program, a charge of $172 related to the Venezuela remeasurement and costs of $5 related to the sale of land in Mexico. For further information regarding the 2012 Restructuring Program, refer to Note 5, Restructuring and Related Implementation Charges. For further information regarding Venezuela, refer to Note 14, Venezuela. For further information regarding the sale of land in Mexico, refer to Note 4, Acquisitions and Divestitures.

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (USD $) In Millions, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Current Assets
Cash and cash equivalents	$ 1,795	$ 962
Receivables (net of allowances of $64 and $67, respectively)	1,670	1,636
Inventories	1,478	1,425
Other current assets	734	799
Total current assets	5,677	4,822
Property, plant and equipment:
Cost	8,363	8,330
Less: Accumulated depreciation	(4,326)	(4,247)
Property, plant and equipment, net	4,037	4,083
Goodwill, net	2,485	2,474
Other intangible assets, net	1,500	1,496
Deferred income taxes	75	77
Other assets	658	924
Total assets	14,432	13,876
Current Liabilities
Notes and loans payable	24	13
Current portion of long-term debt	896	895
Accounts payable	1,264	1,343
Accrued income taxes	253	239
Other accruals	2,265	1,980
Total current liabilities	4,702	4,470
Long-term debt	5,739	4,749
Deferred income taxes	393	444
Other liabilities	1,698	1,677
Total liabilities	12,532	11,340
Shareholders' Equity
Common stock	1,466	1,466
Additional paid-in capital	1,010	1,004
Retained earnings	17,698	17,952
Accumulated other comprehensive income (loss)	(2,537)	(2,451)
Unearned compensation	(26)	(33)
Treasury stock, at cost	(15,981)	(15,633)
Total Colgate-Palmolive Company shareholders' equity	1,630	2,305
Noncontrolling interests	270	231
Total shareholders' equity	1,900	2,536
Total liabilities and shareholders' equity	$ 14,432	$ 13,876

XML

Inventories

3 Months Ended

Mar. 31, 2014

Inventory, Net [Abstract]

Inventories

Inventories

Inventories by major class are as follows:

	March 31, 2014		December 31, 2013
Raw materials and supplies	$	338	$	340
Work-in-process	63		60
Finished goods	1,077		1,025
Total Inventories	$	1,478	$	1,425

XML

Restructuring and Related Implementation Charges

3 Months Ended

Mar. 31, 2014

Restructuring and Related Activities [Abstract]

Restructuring and Related Implementation Charges

Restructuring and Related Implementation Charges

In the fourth quarter of 2012, the Company commenced a four-year Global Growth and Efficiency Program (the “2012 Restructuring Program”) for sustained growth. The program’s initiatives are expected to help Colgate ensure continued solid worldwide growth in unit volume, organic sales and earnings per share and enhance its global leadership positions in its core businesses.

Implementation of the 2012 Restructuring Program is projected to result in cumulative pretax charges, once all phases are approved and implemented, totaling between $1,100 and $1,250 ($775 and $875 aftertax), which are currently estimated to be comprised of the following categories: Employee-Related Costs, including severance, pension and other termination benefits (50%); asset-related costs, primarily Incremental Depreciation and Asset Impairments (15%); and Other charges, which include contract termination costs, consisting primarily of implementation-related charges resulting directly from exit activities (20%) and the implementation of new strategies (15%). Anticipated pretax charges for 2014 are expected to amount to approximately $275 to $325 ($200 to $230 aftertax). Over the course of the 2012 Restructuring Program, it is estimated that approximately 75% of the charges will result in cash expenditures.

It is expected that the cumulative pretax charges, once all projects are approved and implemented, will relate to initiatives undertaken in North America (15%), Europe/South Pacific (20%), Latin America (5%), Asia (5%), Africa/Eurasia (5%), Hill’s Pet Nutrition (10%) and Corporate (40%), which includes substantially all of the costs related to the implementation of new strategies, noted above, on a global basis. It is expected that by the end of 2016, the 2012 Restructuring Program will reduce the Company’s global employee workforce by approximately 6% from the 2012 level of approximately 38,000.

For the three months ended March 31, 2014 and 2013, restructuring and implementation-related charges are reflected in the income statement as follows:

	Three Months Ended March 31,
	2014		2013
Cost of sales	$	10	$	8
Selling, general and administrative expenses	17		8
Other (income) expense, net	75		50
Total 2012 Restructuring Program charges, pretax	$	102	$	66
Total 2012 Restructuring Program charges, aftertax	$	73	$	52

Restructuring and related implementation charges in the preceding table are recorded in the Corporate segment as these initiatives are predominantly centrally directed and controlled and are not included in internal measures of segment operating performance. Total charges for the 2012 Restructuring Program for the three months endedMarch 31, 2014 relate to initiatives undertaken in North America (9%), Europe/South Pacific (21%), Latin America (4%), Africa/Eurasia (2%), Hill’s Pet Nutrition (8%) and Corporate (56%). Total charges for the 2012 Restructuring Program for the three months endedMarch 31, 2013 relate to initiatives undertaken in Europe/South Pacific (31%), Latin America (15%), Africa/Eurasia (6%), Hill’s Pet Nutrition (3%) and Corporate (45%). Total program-to-date accumulated charges for the 2012 Restructuring Program relate to initiatives undertaken in North America (10%), Europe/South Pacific (31%), Latin America (3%), Africa/Eurasia (5%), Hill’s Pet Nutrition (7%) and Corporate (44%).

Since the inception of the 2012 Restructuring Program in the fourth quarter of 2012, the Company has incurred pretax cumulative charges of $562 ($421 aftertax) in connection with the implementation of various projects as follows:

	Cumulative Charges
	as of March 31, 2014
Employee-Related Costs	$	242
Incremental Depreciation	32
Asset Impairments	1
Other	287
Total	$	562

The majority of costs incurred since inception relate to the following projects: restructuring how the Company provides retirement benefits to its U.S.-based employees by shifting them from the Company’s defined benefit retirement plan to the Company’s defined contribution plan; the closing of the Morristown, New Jersey personal care facility; the simplification and streamlining of the Company’s research and development capabilities and oral care supply chain, both in Europe; the consolidation of facilities; the implementation of the Company’s hubbing strategy in Europe; and the extension of shared business services and streamlining global functions.

The following table summarizes the activity for the restructuring and implementation-related charges discussed above and the related accruals:

	Three Months Ended March 31, 2014
	Employee-Related Costs			Incremental Depreciation			Asset Impairments		Other			Total
Balance at December 31, 2013	$	116		$	—		$	—	$	42		$	158
Charges	20			6			—		76			102
Cash payments	(31		)	—			—		(23		)	(54		)
Charges against assets	(1		)	(6		)	—		—			(7		)
Foreign exchange	(1		)	—			—		(1		)	(2		)
Balance at March 31, 2014	$	103		$	—		$	—	$	94		$	197

Employee-Related Costs primarily include severance and other termination benefits and are calculated based on long-standing benefit practices, local statutory requirements and, in certain cases, voluntary termination arrangements. Employee-Related Costs also include pension enhancements amounting to $1 for the three months ended March 31, 2014, which are reflected as Charges against assets within Employee-Related Costs in the preceding tables as the corresponding balance sheet amounts are reflected as a reduction of pension assets or an increase in pension liabilities.

Incremental Depreciation is recorded to reflect changes in useful lives and estimated residual values for long-lived assets that will be taken out of service prior to the end of their normal service period. Asset Impairments are recorded to write down assets held for sale or disposal to their fair value based on amounts expected to be realized. Charges against assets within Asset Impairments are net of cash proceeds pertaining to the sale of certain assets.

Other charges consist primarily of charges resulting directly from exit activities and the implementation of new strategies as a result of the 2012 Restructuring Program. These charges for the three months ended March 31, 2014 included third-party incremental costs related to the development and implementation of new business and strategic initiatives of $16 and contract termination costs and charges resulting directly from exit activities of $21 directly related to the 2012 Restructuring Program. These charges were expensed as incurred. Also included in Other charges for the three months ended March 31, 2014 are other exit costs related to the consolidation of facilities of $39.

XML

Shareholders' Equity (Tables)

3 Months Ended

Mar. 31, 2014

Notes to Financial Statements [Abstract]

Shareholders' Equity

Changes in the components of Shareholders’ Equity for the three months endedMarch 31, 2014 are as follows:

	Colgate-Palmolive Company Shareholders’ Equity																	Noncontrolling Interests
	Common Stock		Additional Paid-in Capital			Unearned Compensation			Treasury Stock			Retained Earnings			Accumulated Other Comprehensive Income (Loss)
Balance, December 31, 2013	$	1,466	$	1,004		$	(33	)	$	(15,633	)	$	17,952		$	(2,451	)	$	231
Net income												388						44
Other comprehensive income (loss), net of tax															(86		)	(1		)
Dividends												(642		)				(4		)
Stock-based compensation expense			34
Shares issued for stock options			9						65
Shares issued for restricted stock awards			(40		)				40
Treasury stock acquired									(453		)
Other			3			7
Balance, March 31, 2014	$	1,466	$	1,010		$	(26	)	$	(15,981	)	$	17,698		$	(2,537	)	$	270

Accumulated other comprehensive income (loss) includes cumulative translation losses of $1,815 and $1,772 at March 31, 2014 and December 31, 2013, respectively, and unrecognized retirement plan and other retiree benefits costs of $722 and $735 at March 31, 2014 and December 31, 2013, respectively.

XML

Fair Value Measurements and Financial Instruments

3 Months Ended

Mar. 31, 2014

Notes to Financial Statements [Abstract]

Fair Value Measurements and Financial Instruments

Fair Value Measurements and Financial Instruments

The Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material, as it is the Company’s policy to contract only with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations.

The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, sourcing strategies, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose. It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged. Hedge ineffectiveness, if any, is not material for any period presented.  

The Company’s derivative instruments include interest rate swap contracts, foreign currency contracts and commodity contracts. The Company utilizes interest rate swap contracts to manage its targeted mix of fixed and floating rate debt, and these swaps are valued using observable benchmark rates (Level 2 valuation). The Company utilizes foreign currency contracts, including forward, option and swap contracts, local currency deposits and local currency borrowings to hedge portions of its foreign currency purchases, assets and liabilities arising in the normal course of business and the net investment in certain foreign subsidiaries. These contracts are valued using observable market rates (Level 2 valuation). Commodity futures contracts are utilized to hedge the purchases of raw materials used in production. These contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of foreign currency and commodity contracts generally does not exceed 12 months.

The following summarizes the fair value of the Company’s derivative instruments and other financial instruments at March 31, 2014 and December 31, 2013:

	Assets					Liabilities
	Account	Fair Value				Account	Fair Value
Designated derivative instruments		3/31/14		12/31/13			3/31/14		12/31/13
Interest rate swap contracts	Other current assets	$	—	$	1	Other accruals	$	—	$	—
Interest rate swap contracts	Other assets	17		20		Other liabilities	7		1
Foreign currency contracts	Other current assets	7		14		Other accruals	7		8
Foreign currency contracts	Other assets	—		—		Other liabilities	7		10
Commodity contracts	Other current assets	1		—		Other accruals	—		—
Total designated		$	25	$	35		$	21	$	19
Derivatives not designated
Foreign currency contracts	Other current assets	$	—	$	—	Other accruals	$	4	$	3
Total not designated		$	—	$	—		$	4	$	3
Total derivative instruments		$	25	$	35		$	25	$	22
Other financial instruments
Marketable securities	Other current assets	$	243	$	173
Available-for-sale securities	Other assets	393		685
Total other financial instruments		$	636	$	858

The carrying amount of cash, cash equivalents, accounts receivable and short-term debt approximated fair value as of March 31, 2014 and December 31, 2013. The estimated fair value of the Company’s long-term debt, including the current portion, as of March 31, 2014 and December 31, 2013, was $6,733 and $5,690, respectively, and the related carrying value was $6,635 and $5,644, respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation).

Fair value hedges

The Company has designated all interest rate swap contracts and certain foreign currency forward and option contracts as fair value hedges, for which the gain or loss on the derivative and the offsetting loss or gain on the hedged item are recognized in current earnings. The impact of foreign currency contracts is primarily recognized in Selling, general and administrative expenses and the impact of interest rate swap contracts is recognized in Interest (income) expense, net.

Activity related to fair value hedges recorded during the three-month periods ended March 31, 2014 and 2013 was as follows:

	2014									2013
	Foreign Currency Contracts			Interest Rate Swaps			Total			Foreign Currency Contracts			Interest Rate Swaps			Total
Notional Value at March 31,	$	681		$	1,688		$	2,369		$	1,085		$	1,338		$	2,423
Three months ended March 31:
Gain (loss) on derivative	2			(10		)	(8		)	12			(7		)	5
Gain (loss) on hedged items	(2		)	10			8			(12		)	7			(5		)

Cash flow hedges

All of the Company’s commodity contracts and certain foreign currency forward contracts have been designated as cash flow hedges, for which the effective portion of the gain or loss is reported as a component of Other comprehensive income (“OCI”) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings.

Activity related to cash flow hedges recorded during the three-month periods ended March 31, 2014 and 2013 was as follows:

	2014						2013
	Foreign Currency Contracts		Commodity Contracts		Total		Foreign Currency Contracts		Commodity Contracts			Total
Notional Value at March 31,	$	401	$	15	$	416	$	446	$	52		$	498
Three months ended March 31:
Gain (loss) recognized in OCI	—		2		2		8		(1		)	7
Gain (loss) reclassified into Cost of sales	2		1		3		3		1			4

The net gain (loss) recognized in OCI for both foreign currency contracts and commodity contracts is expected to be recognized in Cost of sales within the next twelve months.

Net investment hedges

The Company has designated certain foreign currency forward and option contracts and certain foreign currency-denominated debt as net investment hedges, for which the gain or loss on the instrument is reported as a component of Currency translation adjustments within OCI, along with the offsetting gain or loss on the hedged items.

Activity related to net investment hedges recorded during the three-month periods ended March 31, 2014 and 2013 was as follows:

	2014							2013
	Foreign Currency Contracts		Foreign Currency Debt			Total		Foreign Currency Contracts			Foreign Currency Debt			Total
Notional Value at March 31,	$	680	$	256		$	936	$	536		$	375		$	911
Three months ended March 31:
Gain (loss) on instruments	—		1			1		14			13			27
Gain (loss) on hedged items	1		(1		)	—		(13		)	(13		)	(26		)

Derivatives Not Designated as Hedging Instruments

Derivatives not designated as hedging instruments for each period consist of a cross-currency swap that serves as an economic hedge of a foreign currency deposit, for which the gain or loss on the instrument and the offsetting gain or loss on the hedged item are recognized in Other (income) expense, net for each period. 

Activity related to these contracts during the three-month periods ended March 31, 2014 and 2013 was as follows:

	2014			2013
	Cross-currency Swap			Cross-currency Swap
Notional Value at March 31,	$	96		$	96
Three months ended March 31:
Gain (loss) on instrument	(1		)	6
Gain (loss) on hedged item	1			(6		)

Other Financial Instruments

Other financial instruments are classified as Other current assets or Other assets.

Other financial instruments classified as Other current assets include marketable securities, which consist of bank deposits of $195 with original maturities greater than 90 days (Level 1 valuation) and the current portion of bonds issued by the Venezuelan government (Level 2 valuation) in the amount of $48. The long-term portion of these bonds in the amount of $393 is included in Other assets.

Through its subsidiary in Venezuela, the Company is invested in U.S. dollar-linked, devaluation-protected bonds and bolivar denominated fixed interest rate bonds, both of which are issued by the Venezuelan government. These bonds are actively traded and, therefore, are considered Level 2 investments as their values are determined based upon observable market-based inputs or unobservable inputs that are corroborated by market data. As of March 31, 2014, the fair market value of U.S. dollar-linked devaluation-protected bonds and bolivar denominated fixed interest rate bonds was $137 and $304, respectively. These bonds are considered available-for-sale securities and, as noted above, the long-term portion in the amount of $393 is included in Other assets.

The following table presents a reconciliation of the Venezuelan bonds at fair value for the three months endedMarch 31, 2014 and 2013:

	2014			2013
Beginning balance as of January 1,	$	685		$	642
Unrealized gain (loss) on investment	(298		)	(141		)
Purchases and sales during the period	54			97
Ending balance as of March 31,	$	441		$	598

Unrealized loss on investment for the three months ended March 31, 2014 consisted primarily of a charge in the amount of $276 related to the remeasurement of the bolivar denominated fixed interest rate bonds and the devaluation-protected bonds in Venezuela as a result of the effective devaluation in the first quarter of 2014.

Unrealized loss on investment for the three months ended March 31, 2013 consisted primarily of a charge in the amount of $133 only related to the remeasurement of the bolivar denominated fixed interest rate bonds in Venezuela as a result of the devaluation in the first quarter of 2013. No remeasurement charge was required on the devaluation-protected bonds in the first quarter of 2013 since the official exchange rate changed from 4.30 to 6.30 bolivares per dollar and the devaluation-protected bonds revalued to the official exchange rate.

For further information regarding Venezuela, refer to Note 14, Venezuela.

XML

Other Comprehensive Income (Loss)

3 Months Ended

Mar. 31, 2014

Other Comprehensive Income (Loss) [Abstract]

Comprehensive Income (Loss) Other

Other Comprehensive Income (Loss)

Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the three months endedMarch 31, 2014 and 2013 were as follows:

	2014						2013
	Pretax			Net of Tax			Pretax			Net of Tax
Cumulative translation adjustments	$	(39	)	$	(43	)	$	(45	)	$	(55	)
Retirement plans and other retiree benefits:
Net actuarial gain (loss) and prior service costs arising during the period	3			2			3			2
Amortization of net actuarial loss, transition and prior service costs (1)	14			11			26			18
Retirement plans and other retiree benefits adjustments	17			13			29			20
Available-for-sale securities:
Unrealized gains (losses) on available-for-sale securities (2)	(298		)	(194		)	(141		)	(90		)
Reclassification of (gains) losses into net earnings on available-for-sale securities (3)	211			138			133			86
Gains (losses) on available-for-sale securities	(87		)	(56		)	(8		)	(4		)
Cash flow hedges:
Unrealized gains (losses) on cash flow hedges	2			1			7			5
Reclassification of (gains) losses into net earnings on cash flow hedges (4)	(3		)	(1		)	(4		)	(3		)
Gains (losses) on cash flow hedges	(1		)	—			3			2
Total Other comprehensive income (loss)	$	(110	)	$	(86	)	$	(21	)	$	(37	)

⁽¹⁾These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 10, Retirement Plans and Other Retiree Benefits for additional details.

⁽²⁾For the three months ended March 31, 2014, these amounts included pretax losses of $276 related to the remeasurement of the bolivar denominated fixed interest rate bonds and the devaluation-protected bonds in Venezuela as a result of the effective devaluation in the first quarter of 2014.

For the three months ended March 31, 2013, these amounts included pretax losses of $133 only related to the remeasurement of the bolivar denominated fixed interest rate bonds in Venezuela as a result of the devaluation in the first quarter of 2013. No remeasurement charge was required on the devaluation-protected bonds in the first quarter of 2013 since the official exchange rate changed from 4.30 to 6.30 bolivares per dollar and the devaluation-protected bonds revalued to the official exchange rate. See Note 13, Fair Value Measurements and Financial Instruments for additional details.

⁽³⁾Represents reclassification of (gains) losses on the Venezuela bonds into Other (income) expense, net due to an impairment in the fair value of the bonds as a result of the effective devaluation in the first quarter of 2014 and the devaluation in the first quarter of 2013. See Note 13, Fair Value Measurements and Financial Instruments for additional details.

⁽⁴⁾These (gains) losses are reclassified into Cost of sales. See Note 13, Fair Value Measurements and Financial Instruments for additional details.

There were no tax impacts on Other comprehensive income (loss) attributable to Noncontrolling interests.

XML

Shareholders' Equity

3 Months Ended

Mar. 31, 2014

Notes to Financial Statements [Abstract]

Stockholders' Equity

Shareholders’ Equity

Changes in the components of Shareholders’ Equity for the three months endedMarch 31, 2014 are as follows:

	Colgate-Palmolive Company Shareholders’ Equity																	Noncontrolling Interests
	Common Stock		Additional Paid-in Capital			Unearned Compensation			Treasury Stock			Retained Earnings			Accumulated Other Comprehensive Income (Loss)
Balance, December 31, 2013	$	1,466	$	1,004		$	(33	)	$	(15,633	)	$	17,952		$	(2,451	)	$	231
Net income												388						44
Other comprehensive income (loss), net of tax															(86		)	(1		)
Dividends												(642		)				(4		)
Stock-based compensation expense			34
Shares issued for stock options			9						65
Shares issued for restricted stock awards			(40		)				40
Treasury stock acquired									(453		)
Other			3			7
Balance, March 31, 2014	$	1,466	$	1,010		$	(26	)	$	(15,981	)	$	17,698		$	(2,537	)	$	270

Accumulated other comprehensive income (loss) includes cumulative translation losses of $1,815 and $1,772 at March 31, 2014 and December 31, 2013, respectively, and unrecognized retirement plan and other retiree benefits costs of $722 and $735 at March 31, 2014 and December 31, 2013, respectively.

XML

Earnings Per Share

3 Months Ended

Mar. 31, 2014

Earnings Per Share [Abstract]

Earnings Per Share

Earnings Per Share

	Three Months Ended
	March 31, 2014					March 31, 2013
	Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share
Basic EPS	$	388	919.5	$	0.42	$	460	936.6	$	0.49
Stock options and restricted stock			9.1					8.4
Diluted EPS	$	388	928.6	$	0.42	$	460	945.0	$	0.48

For the three months endedMarch 31, 2014 and 2013, the average number of stock options and restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 3,374,995 and 3,750,570, respectively.

Basic and diluted earnings per share are computed independently for each quarter and any year-to-date period presented. As a result of changes in shares outstanding during the year and rounding, the sum of the quarters’ earnings per share may not necessarily equal the earnings per share for any year-to-date period.

XML

Retirement Plans and Other Retiree Benefits

3 Months Ended

Mar. 31, 2014

Notes to Financial Statements [Abstract]

Retirement Plans and Other Retiree Benefits

Retirement Plans and Other Retiree Benefits

Components of Net periodic benefit cost for the three-month periods ended March 31, 2014 and 2013 were as follows:

	Pension Benefits												Other Retiree Benefits
	United States						International
	Three Months Ended March 31,
	2014			2013			2014			2013			2014		2013
Service cost	$	—		$	7		$	5		$	6		$	3	$	4
Interest cost	25			23			9			7			10		10
Expected return on plan assets	(27		)	(29		)	(7		)	(6		)	—		(1		)
Amortization of transition and prior service costs (credits)	—			2			1			—			—		—
Amortization of actuarial loss (gain)	8			16			1			3			4		5
Net periodic benefit cost	$	6		$	19		$	9		$	10		$	17	$	18

For each of the three months endedMarch 31, 2014 and 2013, the Company did not make any voluntary contributions to its U.S. postretirement plans.

XML

Shareholders' Equity (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013
Changes in Shareholders' Equity [Roll Forward]
Beginning balance	$ 2,536
Net income	432	506
Other comprehensive income, net of tax	(87)	(37)
Ending balance	1,900
Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax	1,815		1,772
Accumulated Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Net of Tax	722		735
Common Stock [Member]
Changes in Shareholders' Equity [Roll Forward]
Beginning balance			1,466
Ending balance	1,466		1,466
Additional Paid-In Capital [Member]
Changes in Shareholders' Equity [Roll Forward]
Beginning balance	1,004
Stock-based compensation expense	34
Shares issued for stock options	9
Stock issued for restricted stock awards	(40)
Other	3
Ending balance	1,010
Unearned Compensation [Member]
Changes in Shareholders' Equity [Roll Forward]
Beginning balance	(33)
Other	7
Ending balance	(26)
Treasury Stock [Member]
Changes in Shareholders' Equity [Roll Forward]
Beginning balance	(15,633)
Shares issued for stock options	65
Stock issued for restricted stock awards	40
Treasury stock acquired	(453)
Other
Ending balance	(15,981)
Retained Earnings [Member]
Changes in Shareholders' Equity [Roll Forward]
Beginning balance	17,952
Net income	388
Dividends	(642)
Ending balance	17,698
Accumulated Other Comprehensive Income (Loss) [Member]
Changes in Shareholders' Equity [Roll Forward]
Beginning balance	(2,451)
Other comprehensive income, net of tax	(86)
Ending balance	(2,537)
Noncontrolling Interests [Member]
Changes in Shareholders' Equity [Roll Forward]
Beginning balance	231
Net income	44
Other comprehensive income, net of tax	(1)
Dividends	(4)
Ending balance	$ 270

XML

Restructuring and Related Implementation Charges (Tables)

3 Months Ended

Mar. 31, 2014

Restructuring and Related Activities [Abstract]

Schedule of Restructuring and Related Costs

For the three months ended March 31, 2014 and 2013, restructuring and implementation-related charges are reflected in the income statement as follows:

	Three Months Ended March 31,
	2014		2013
Cost of sales	$	10	$	8
Selling, general and administrative expenses	17		8
Other (income) expense, net	75		50
Total 2012 Restructuring Program charges, pretax	$	102	$	66
Total 2012 Restructuring Program charges, aftertax	$	73	$	52

Schedule of Restructuring and Related Costs Incurred to Date

Since the inception of the 2012 Restructuring Program in the fourth quarter of 2012, the Company has incurred pretax cumulative charges of $562 ($421 aftertax) in connection with the implementation of various projects as follows:

	Cumulative Charges
	as of March 31, 2014
Employee-Related Costs	$	242
Incremental Depreciation	32
Asset Impairments	1
Other	287
Total	$	562

Schedule of Restructuring Reserve by Type of Cost

The following table summarizes the activity for the restructuring and implementation-related charges discussed above and the related accruals:

	Three Months Ended March 31, 2014
	Employee-Related Costs			Incremental Depreciation			Asset Impairments		Other			Total
Balance at December 31, 2013	$	116		$	—		$	—	$	42		$	158
Charges	20			6			—		76			102
Cash payments	(31		)	—			—		(23		)	(54		)
Charges against assets	(1		)	(6		)	—		—			(7		)
Foreign exchange	(1		)	—			—		(1		)	(2		)
Balance at March 31, 2014	$	103		$	—		$	—	$	94		$	197

XML

Retirement Plans and Other Retiree Benefits (Tables)

3 Months Ended

Mar. 31, 2014

Notes to Financial Statements [Abstract]

Components Of Net Periodic Benefit Cost

Components of Net periodic benefit cost for the three-month periods ended March 31, 2014 and 2013 were as follows:

	Pension Benefits												Other Retiree Benefits
	United States						International
	Three Months Ended March 31,
	2014			2013			2014			2013			2014		2013
Service cost	$	—		$	7		$	5		$	6		$	3	$	4
Interest cost	25			23			9			7			10		10
Expected return on plan assets	(27		)	(29		)	(7		)	(6		)	—		(1		)
Amortization of transition and prior service costs (credits)	—			2			1			—			—		—
Amortization of actuarial loss (gain)	8			16			1			3			4		5
Net periodic benefit cost	$	6		$	19		$	9		$	10		$	17	$	18

XML

Fair Value Measurements and Financial Instruments (Details 2) (USD $) In Millions, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Carrying Value [Member]
Debt Instrument [Line Items]
Long-term debt	$ 6,635	$ 5,644
Fair Value, Inputs, Level 2 [Member]
Debt Instrument [Line Items]
Debt Instrument, Fair Value Disclosure	$ 6,733	$ 5,690

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parentheticals) (USD $) In Millions, unless otherwise specified	Mar. 31, 2014	Dec. 31, 2013
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 64	$ 67

XML

Acquisitions and Divestitures

3 Months Ended

Mar. 31, 2014

Notes to Financial Statements [Abstract]

Acquisitions and Divestitures

Acquisitions and Divestitures

Sale of Land in Mexico

On September 13, 2011, the Company’s Mexican subsidiary entered into an agreement to sell to the United States of America the Mexico City site on which its commercial operations, technology center and soap production facility are located. The sale price is payable in three installments, with the final installment due upon the transfer of the property, which is expected to occur in 2014. During the third quarter of 2011, the Company received the first installment of $24 upon signing the agreement. During the third quarter of 2012, the Company received the second installment of $36. The Company is reinvesting these payments to relocate its soap production to a new state-of-the-art facility at its Mission Hills, Mexico site, to relocate its commercial and technology operations within Mexico City and to prepare the existing site for transfer. Exit costs incurred during the project primarily relate to staff leaving indemnities, accelerated depreciation and demolition to make the site building-ready. During the three months endedMarch 31, 2014 and 2013, the Company recorded $1 and $5 of pretax costs ($1 and $3 of aftertax costs), respectively, related to the sale.

XML

Segment Information (Tables)

3 Months Ended

Mar. 31, 2014

Notes to Financial Statements [Abstract]

Net Sales and Operating Profit by Segment

Net sales and Operating profit by segment were as follows:

	Three Months Ended
	March 31,
	2014			2013
Net sales
Oral, Personal and Home Care
North America	$	785		$	764
Latin America	1,152			1,214
Europe/South Pacific	865			848
Asia	672			655
Africa/Eurasia	298			300
Total Oral, Personal and Home Care	3,772			3,781
Pet Nutrition	553			534
Total Net sales	$	4,325		$	4,315
Operating profit
Oral, Personal and Home Care
North America	$	216		$	215
Latin America	290			312
Europe/South Pacific	217			200
Asia	193			186
Africa/Eurasia	59			62
Total Oral, Personal and Home Care	975			975
Pet Nutrition	144			136
Corporate	(485		)	(369		)
Total Operating profit	$	634		$	742

XML

Contingencies (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2014 country_and_territory	Oct. 09, 2013
Loss Contingency [Abstract]
Minimum Number Of Countries And Territories Serving Consumers	200
Range of reasonably possible losses, minimum	$ 0
Range of reasonably possible losses, maximum	250
Brazilian internal revenue authority, matter 1	120
Brazilian internal revenue authority, matter 2	75
European competition matters - Swiss competition law authority	6
European competition matters - Spanish competition law authority	3
European competition matters - Italian competition law authority	3
European competition matters - Hill's France Subsidiary	7
Fine Imposed French competition authority	46
ERISA Matter		$ 40

XML

Venezuela

3 Months Ended

Mar. 31, 2014

Notes to Financial Statements [Abstract]

Venezuela

Venezuela

Venezuela has been designated hyper-inflationary and, therefore, the functional currency for the Company’s Venezuelan subsidiary (“CP Venezuela”) is the U.S. dollar and Venezuelan currency fluctuations are reported in income.

During the first quarter of 2014, the Venezuelan government enacted several changes to Venezuela’s foreign exchange regime, introducing a multi-tier foreign exchange system whereby there are now three exchange rate mechanisms available to convert Venezuelan bolivares to U.S. dollars. The Venezuelan government replaced CADIVI with a new foreign currency administration, the National Center for Foreign Commerce (“CENCOEX”). Although the official exchange rate remains at 6.30 bolivares per dollar, the exchange rate for foreign investments moved to the rate available on the SICAD I (Supplementary System for the Administration of Foreign Currency) currency market which, in the last auction during the first quarter of 2014, was 10.70 bolivares per dollar. As part of the changes in Venezuela’s foreign exchange system enacted in the first quarter of 2014, the Venezuelan government also introduced an alternative currency market known as SICAD II.

The Company remeasures the financial statements of CP Venezuela at the end of each month at the rate at which it expects to remit future dividends which, based on the advice of legal counsel, is the SICAD I rate. Effective with the quarter ended March 31, 2014, the Company remeasured the majority of CP Venezuela’s local currency-denominated net monetary assets at the quarter-end SICAD I rate and incurred a pretax loss of $266 ($174 aftertax loss or $0.19 per diluted common share). Included in the loss is a charge related to the devaluation-protected bonds issued by the Venezuelan government and held by CP Venezuela. Because the official exchange rate remains at 6.30 bolivares per dollar, the devaluation-protected bonds did not revalue at the rate available on the SICAD I currency market but remained at the official exchange rate. CP Venezuela continues to be able to settle certain of its U.S. dollar obligations for imported materials at the official rate of 6.30 bolivares per dollar and records the gains related to such transactions when the funds are authorized by CENCOEX and the liabilities are paid.

In the first quarter of 2013, the Company incurred a pretax loss of $172 ($111 aftertax loss) related to the remeasurement of the net monetary assets in the local balance sheet at the date of the devaluation that changed the official exchange rate from 4.30 to 6.30 bolivares per dollar.

For the three months endedMarch 31, 2014, CP Venezuela represented approximately 3% of the Company’s consolidated Net sales. CP Venezuela incurred a small operating loss for the quarter ended March 31, 2014, which was insignificant in relation to the Company’s consolidated Operating profit. At March 31, 2014, CP Venezuela’s local currency-denominated net monetary asset position, which would be subject to remeasurement in the event of further changes in the SICAD I rate, was approximately $489. This amount includes the devaluation-protected bonds issued by the Venezuelan government. CP Venezuela’s local currency-denominated non-monetary assets were approximately $337 at March 31, 2014 and included approximately $226 of fixed assets that could be subject to impairment if CP Venezuela continues to be unable to implement price increases to offset the impacts of continued high inflation or further devaluations, or if it does not have sufficient access to U.S. dollars to fund imports.